Alpdoğan Kantarci, DDS, PhD, CAGS

Professor
Headshot of Alpdogan Kantarci

Contact

Office Address

7-194 Moos Tower
515 Delaware St SE
Minneapolis, MN 55455
United States

Affiliations:
Department of Developmental and Surgical Sciences,
Division of Periodontology

Titles

Chair, Department of Developmental and Surgical Sciences
Erwin M. Schaffer Chair in Periodontal Research

Education

CAGS, Periodontology, Boston University Goldman School of Dental Medicine, Department of Periodontology and Oral Biology

PhD/Doctorate in Periodontology, University of Istanbul, Faculty of Dentistry, Department of Periodontology

DDS, MSc in Dentistry, University of Istanbul, Faculty of Dentistry

BA, Robert College of Istanbul

Diplomate, American Board of Periodontology

Licensures and Certifications

American Academy of Periodontology (Board certified)
American Dental Association
Massachusetts Dental Society
International Association of Dental Research
American Association of Dental Research
International Academy of Periodontology
Society of Neuroscience

Expand all

Biography

Dr. Alpdoğan Kantarci holds a DDS and a PhD. He is a Board certified specialist of periodontology and a Diplomate of the American Board of Periodontology. He is the Erwin Schaeffer Endowed Chair, professor and Chair of the Department of Developmental and Surgical Sciences at the University of Minnesota School of Dentistry. 

He was previously a professor and senior member of the staff at the ADA Forsyth Institute and a faculty member at Harvard University School of Dental Medicine and Boston University’s Henry Goldman School of Dental Medicine. 

He completed his doctorate studies at Istanbul University's Department of Periodontology and moved to the US as a postdoctoral fellow at Boston University. He completed his clinical periodontology specialization training (CAGS) at Boston University. 

He served as the clinical director at the ADA Forsyth Institute and continues to work as an active periodontist and implantologist. 

Dr. Kantarci has mentored more than 60 theses and directed and taught in several graduate and postgraduate clinical and didactic dentistry courses. He serves on the editorial board of more than 20 dental and medical scientific journals. 

His research interests include Molecular Mechanisms and Resolution Pathways of Oral Inflammation in Periodontitis and the Link to Systemic Diseases, Experimental Models, Clinical Applications of High-Throughput Analysis in Dental Research (e.g. xMAP Multiplexing), and Biology of Tooth Movement. He holds several patents. 

He has published more than 220 articles in peer-reviewed scientific journals, written book chapters, and presented more than 500 oral talks.

Research interests

  • Molecular Mechanisms and Resolution Pathways of Oral Inflammation in Periodontitis and Inflammatory Diseases
  • Link between Periodontal Disease and Neurodegenerative Diseases
  • Biology of Accelerated Tooth Movement
  • Regeneration, Wound Healing, and Pathogenesis of Gingival Fibrosis
  • Experimental Animal Models
  • Clinical Applications of High-Throughput Analysis and Salivary Diagnostics 

Honors and Recognitions

  • Erwin Shaeffer Endowed Chair, University of Minnesota 2025
  • Dean’s Award for Scientific Excellence, Boston University 2006
  • Associate Professor in Periodontology (Turkey) 2004
  • NATO Postdoctoral Research Science Fellowship B-1  1999
  • Best Research Award of Turkish Society of Periodontology  1997
  • University of Istanbul, Faculty of Dentistry, Dean’s Award 1996
  • Science and Technology Research Council of Turkey (TUBITAK)
  • International Representation Award 1996
  • Best Research Award of Turkish Society of Periodontology 1995

Grants and Patents

Patents

  1. Delivery of H2 antagonists in liposomes; Inventors: Thomas E. Van Dyke, Michael Holick, Alpdogan Kantarci, Hatice Hasturk
  2. Methods for increasing oral osteogenesis using lipoxin A4 (LXA4) and its analogs; Inventors: Thomas E. Van Dyke, Hatice Hasturk, Alpdogan Kantarci
  3. Compositions and methods of treating cancer using lipid agonists and receptors thereof; Inventors: Alpdogan Kantarci, Shevali Kansal, Hatice Hasturk, Thomas E. Van Dyke
  4. Methods for stabilizing atherosclerotic plaques using lipoxins, resolvins, and analogs thereof Inventors: Thomas E. Van Dyke, Hatice Hasturk, Alpdogan Kantarci
  5. Hygromycin A for treatment of Oral Diseases and Infections. Inventors: Matthew Charles Tindall, Alpdogan Kantarci, Xuesong He, Ozge Unlu, Nil Yakar Yilmaz, Lujia Cen

 

Grants

  1. RC1 DE020404-01 09/09-08/11 Wactawaski-Wende (PI) NIH/NIDCR. “Saliva and Serum Inflammatory Biomarkers in Periodontitis: A Study in Older Women” (Consortium Principal Investigator)
  2. Straumann-One Kantarci (PI) 01/01/12 - 12/31/15 “A Randomized, Controlled, Multicenter Clinical Study Evaluating the Outcomes of Periodontal Surgery in Supra-Alveloar-Type Defects with or without Straumann® Emdogain” (Principal Investigator)
  3. Luminous  Kantarci (PI) 01/25/12 - 12/31/13 “Vitamin D and Photobiomodulation-induced Orthodontic Tooth Movement” (Principal Investigator)
  4. R21-DE020906-02 Kantarci (PI) 03/03/11 - 02/28/13 NIH/NIDCR “Hypoxia and PMN Function in Periodontitis” (Principal Investigator)
  5. R01-DE012768-01 Darveau (PI) 06/01/11 - 05/31/15 NIH/NIDCR “P gingivalis LPS: Hemin-induced Lipid A Structural Remodeling” (Principal Investigator-Sub-Award)
  6. R56 DE023950 Henderson/Gibson (PIs) 09/25/13 - 08/31/15 NIH/NIDCR “Oral Macrophage Function in the Context of Periodontal Disease and HIV Function” (Principal Investigator-Sub-Award)
  7. Resolvyx 01/06-12/06 “Development of In Vitro Drug Screening Methods” (Principal Investigator)
  8. Biolux 06/08-05/09 “LED-induced Photobiomodulation as an Adjunct to Orthodontic Tooth Movement” (Principal Investigator)
  9. Research Fund of University of Istanbul, Ö-210/240696, 96-97 “Evaluation of the expression of HLA distribution in phenytoin-induced gingival overgrowth” (Principal Investigator)
  10. Research Fund of University of Istanbul, Ö-III/29/150497, 97-98 “Clinical effects of periodontal treatment on the severity of cyclosporine-A induced gingival hyperplasia” (Principal Investigator)
  11. NATO Postdoctoral Research Science Fellowship B-1 B.02.1.BAK.0.09.00.00 (99) 736-1931, 99-00 “Analysis of Diacylglycerol Kinase and Its Relevance to Defective Neutrophil Response in Localized Juvenile Periodontitis” (Principal Investigator)
  12. R01-DE025020-01Van Dyke (PI) 05/01/15-04/30/20 NIH/NIDCR “Mechanisms of Resolvin E1 in Periodontal Regeneration” (Co-investigator)
  13. R01-DE015566-10 Van Dyke (PI) 12/01/03 - 06/30/15 NIH/NIDCR “Neutrophils and Periodontitis in Diabetes” (Co-investigator)
  14. Cele H. & William B. Rubin Family Fund, Inc. Morse (PI) 12/16/13 – 12/15/14 “Dental Stem Cells for Neuro-regeneration” (Co-investigator)
  15. SunStar Hasturk (PI) 03/01/13 - 04/30/14 “A Clinical Trial to Evaluate Long-Term Efficacy and Safety of Lozenges containing Lactobacillus reuteri (Prodentis™) on Gingivitis” (Co-investigator)
  16. 3D Matrix, Inc. Clinical Study Van Dyke (PI) 09/01/11 - 08/31/14 “A Prospective, Single-Blind, Randomized, Controlled Feasibility Study of PuraMatrix Bone Void Filler vs. Demineralized Freeze-Dried Bone Allograft in Dental Alveolar Sinus Lift Procedures” (Co-investigator)
  17. Procter and Gamble Co.  Hasturk (PI) 04/01/12 - 08/31/13 “Effect of Aging on the Gene Expression and Histomorphology of Dental Gum Tissue”(Co-investigator)
  18. R01-DE019938-03 Serhan/Van Dyke (Multiple PIs) 07/17/09 - 05/31/13 NIH/NIDCR “Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction” (Co-investigator)
  19. R21 DE14478 Van Dyke (PI) 09/01-08/03 NIH/NIDCR “Periodontal Inflammation in Type I Diabetes” (Co-investigator)
  20. R29 DE11004 Trackman (PI) 01/07-06/12 NIH/NIDCR “Growth Factors and Gingival Fibrosis” (Co-investigator)
  21. P01 DE13199 Van Dyke, Project 3 (PI) 04/00-3/05 NIH Program Project “Modulation of Molecular Pathogenesis in Systemic Diseases” (Co-investigator)
  22. P01 DE13499 Van Dyke, Project 2 (PI) 04/00-03/05 NIH Program Project "Molecular Mechanisms in Leukocyte-Mediated Tissue Injury" (Co-investigator)
  23. P50 DE16199 Serhan (PI) 09/04-09/09 NIH Program Project “Novel Lipid Mediators in LAP and Resolution” (Co-investigator)
  24. R01-DE019938-03 CN Serhan/TE.Van Dyke (Multiple PI) 07/09 - 05/13 NIH/NIDCR “Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction” (Co-investigator)
  25. Interleukin Genetics (PI. TE. Van Dyke) 04/02-03/03 “IL-1B Genotype Association with Chemokine and Chemokine Receptor Expression” (Co-investigator)
  26. Broad Research Institute (PI, Lisa Ganley-Leal) 11/08-10/10 “Human B cells as potential mediators of inflammation in chronic inflammatory disease” (Co-Investigator)
  27. Boston University Evans Center for Interdisciplinary Biomedical Research Affinity Research Collaborative (ARC) Grant (Co-Directors: Marie McDonnell, Lisa Ganley-Leal) 09-12 “Blood Microbiome” (Co-Investigator)
  28. Ilene Beal Charitable Foundation Kantarci (PI) 02/25/17-02/23/18 Limiting Cancer Cell-induced Inflammation by Resolution of the Inflammatory Pathways (Principal Investigator)
  29. R01DE025020-04S1 (Van Dyke) 09/01/18-06/30/19 NIH/NIDCR Mechanisms of Resolvin E1 in Periodontal Regeneration (Co-Investigator)
  30. R01AG062496-01 (Co-PI: Kantarci with Dr. Dedeoglu) 07/01/19 – 04/30/24 NIH/NIA Mechanistic Link Between Alzheimer’s Disease and Periodontitis
  31. R01-DE025020-05 Van Dyke, TE (PI) 05/01/15-06/30/24 NIH; NIDCR Mechanisms of Pro-Resolving Mediators in Periodontal Regeneration (Co-Investigator)
  32. R21 EY028209-01A1 (Chiu) 09/30/18 – 08/31/20 NIH/NEI Infection of a Keystone Bacterium for Periodontitis and Age-related Macular Degeneration (Co-Investigator)

Publications and presentations

Published articles

  1. Firatli, E., Kantarci, A., Cebeci, İ., Tanyeri, H., Sönmez, G., Çarin, M., Tuncer, Ö. The distribution of HLA antigens in juvenile and rapidly progressive periodontitis. Journal of Clinical Periodontology 1996; 23: 563 - 566.
  2. Cebeci, İ., Kantarci, A., Firatli, E., Aygün, S., Tanyeri, H., Aydın, A.E., Çarin, M., Güç, Ü, Tuncer, Ö. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. Journal of Clinical Periodontology 1996; 23: 737 - 742.
  3. Kantarci, A., Cebeci, İ., Firatli, E., Atamer T., Tuncer Ö. Periodontal management of Glanzmann’s Thrombasthenia: Report of 3 cases. Journal of Periodontology 1996; 67: 816 - 820.
  4. Cebeci, İ., Kantarci, A., Firatli, E., Çarin, M., Tuncer, Ö.  The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth. Journal of Periodontology 1996; 67; 1201 - 1205.
  5. Cebeci, İ., Kantarci, A., Tanyeri, H., Çintan, S., Alatlı, C., Tuncer, Ö. Cyclosporine-A Induced Gingival Overgrowth in Heart Transplantation-Report of a Case. Dişhekimliğinde Klinik 1997; 10: 47-49.
  6. Cebeci, İ., Kantarci, A., Gürel, N., Adın, S., Tuncer, Ö, Badur, S., Firatli, E. Analysis of Peripheral Blood Leukocytes in Patients with Cyclosporine-A induced Gingival Hyperplasia. Journal of Periodontology 1998; 69; 1435 - 1439.
  7. Kantarci, A., Cebeci, İ., Tuncer, Ö, Çarin, M., Firatli, E. The Clinical Effects of Periodontal Treatment on the Severity of Cyclosporine-A induced Gingival Hyperplasia. Journal of Periodontology 1999; 70: 585 - 591.
  8. Uzel, M.I, Kantarci, A., Hong, H-H., Uygur, C., Sheff, M.C., Firatli, E., Trackman, P.C. Connective Tissue Growth Factor in Drug-Induced Gingival Overgrowth. Journal of Periodontology 2001; 72: 919 – 929.
  9. Kantarci A, Van Dyke TE. Neutrophil-Mediated Host Response to Porphyromonas gingivalis. Journal of International Academy of Periodontology 2002; 4: 119 – 125.
  10. Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil-Mediated Tissue Injury in Periodontal Disease Pathogenesis: Findings from Localized Aggressive Periodontitis. Journal of Periodontology, 2003; 74: 66 - 75.
  11. Kantarci A, Van Dyke TE. Lipoxins and Chronic Inflammation. Critical Reviews in Oral Biology and Medicine 2003; 14: 4 – 12.
  12. Gyurko R, Boustany G, Huang PL, Kantarci A, Van Dyke TE, Genco CA, Gibson FC. Mice Lacking Inducible Nitric Oxide Synthase Demonstrate Impaired Killing of the Periodontal Pathogen Porphyromonas gingivalis. Infection and Immunity, 2003; 71: 4917 – 4924.
  13. Oyaizu K, Kantarci A, Maeda H, Batista Jr EL, Hasturk H, Murayama Y, Badwey JA, Van Dyke TE. Identification of mRNA for Various Diacylglycerol Kinase Isoforms in Neutrophils from Patients with Localized Aggressive Periodontitis. Journal of Periodontal Research, 2003; 38: 488 – 495.
  14. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE. Reduced Inflammation and Tissue Damage in Transgenic Rabbits Overexpressing 15-Lipoxygenase and Endogenous Anti-inflammatory Lipid Mediators. Journal of Immunology, 2003; 171: 6856 - 6865.
  15. Li Y, Xu L, Hasturk H, Kantarci A, Wu D, DePalma S, Van Dyke TE. Localized Aggressive Periodontitis is linked to Human Chromosome 1q25. Human Genetics, 2004; 114: 291-297.
  16. Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H, Badwey JA, Colgan SP, Van Dyke TE, Serhan CN. A Molecular Defect in Intracellular Lipid Signaling in Human Neutrophils in Localized Aggressive Periodontal Tissue Damage. Journal of Immunology, 2004; 172: 1856 - 1861.
  17. Donley CL, Badovinac R, Sapir S, Shapira L, Houri Y, Kantarci A, Warbington ML, Dibart S, Van Dyke TE, Needleman HL, Karimbux N, Bimstein E. IgG levels to Porphyromonas gingivalis and Clinical Measures in Children. Journal of Periodontology, 2004; 75: 205 - 212.
  18. Iontcheva I, Amar S, Zawawi KH, Kantarci A, Van Dyke TE. A Role for Moesin in Lipopolysaccharide Stimulated Signal Transduction. Infection and Immunity, 2004; 72: 2312 – 2320.
  19. Casavecchia P, Uzel MI, Kantarci A, Hasturk H, Dibart S, Hart TC, Trackman PC, Van Dyke TE. Hereditary Gingival Fibromatosis Associated with Aggressive Periodontitis. Journal of Periodontology, 2004: 75: 770 – 778.
  20. Trackman PC, Kantarci A. Connective Tissue Metabolism and Gingival Overgrowth. Critical Reviews in Oral Biology and Medicine, 2004: 15: 165 - 175.
  21. Berker E, Kantarci A, Hasturk H, Van Dyke TE. Effect of Neutrophil Apoptosis on Monocytic Cytokine Response to Porphyromonas gingivalis Lipopolysaccharide. Journal of Periodontology, 2005: 76: 964 - 971.
  22. Herrmann JM, Kantarci A, Long H, Bernardo J, Hasturk H, Wray LV, Jr., Simons ER, Van Dyke TE. Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients. Journal of Leukocyte Biology, 2005: 78: 612-619.
  23. Kantarci A, Van Dyke TE. Lipoxin Signaling in Neutrophils and Their Role in Periodontal Disease. Prostaglandins Leukotrienes Essential Fatty Acids, 2005: 73: 289-299.
  24. Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam B-H, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE. Enhanced Superoxide Release and Elevated Protein Kinase C Activity in Neutrophils from Diabetic Patients: Association with Periodontitis. Journal of Leukocyte Biology, 2005: 78: 862-870.
  25. Fujita T, Kantarci A, Warbington ML, Zawawi KH, Hasturk H, Kurihara H, Van Dyke TE. CD38 Expression by Neutrophils from Patients with Localized Aggressive Periodontitis (LAP). Journal of Periodontology, 2005; 76: 1960-1965.
  26. Kantarci A, Van Dyke TE. Resolution of Inflammation in Periodontitis. Journal of Periodontology, 2005; 76: 2168-2174.
  27. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis N, Levy BD, Serhan CN, Van Dyke TE. RvE1 Protects from Local Inflammation and Osteoclast Mediated Bone Destruction in Periodontitis. FASEB Journal, 2006; 20: 401-403.
  28. Kantarci A, Hasturk H, Van Dyke TE. Host-Mediated Resolution of Inflammation in Periodontal Diseases. Periodontology 2000, 2006; 40: 144-163.
  29. Hasturk H, Kantarci A, Ebrahimi N, Andry C, Holick M, Jones VL, Van Dyke TE. Topical H2-Antagonist Prevents Periodontitis in a Rabbit Model. Infection and Immunity, 2006; 74: 2402-2414.
  30. Kantarci A, Black SA, Xydas C, Murawel P, Uchida Y, Atilla G,  Uzel MI, Firatli E, Sheff M, Hasturk H, Van Dyke TE, Trackman PC. Epithelial and Connective Tissue Cell CTGF/CCN2 expression in Gingival Fibrosis. Journal of Pathology 2006, 210: 59-66.
  31. Ariel A, Fredman G, Sun Y-P, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nature Immunology 2006, 7: 1209-1216.
  32. Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE. Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice. Journal of Immunology 2006, 177: 7250-7256.
  33. Ding Y, Kantarci A, Hasturk H, Trackman PC, Malabanan A, Van Dyke TE. Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. Journal of Leukocyte Biology, 2007; 81: 520 – 527.
  34. Nassar H, Kantarci A, Van Dyke TE. Diabetic Periodontitis: A Model for Activated Innate Immunity and Impaired Resolution of Inflammation. Periodontology 2000, 2007; 43: 233-244.
  35. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu HS, Alshahat M, Van Dyke TE. Platelet-Rich Plasma: Growth Factors, Pro- and Anti-Inflammatory Properties. Journal of Periodontology, 2007; 78: 661-669.
  36. Yassibag-Berkman Z, Tuncer O, Subasioglu T, Kantarci A. Combined Use of Platelet Rich Plasma and Bone Grafting with or without Guided Tissue Regeneration in the Treatment of Anterior Interproximal Defects. Journal of Periodontology, 2007; 78: 801 – 809.
  37. Hasturk H, Jones VL. Andry C, Kantarci A. 1-Tetradecanol Complex Reduces Progression of Porphyromonas gingivalis-induced Experimental Periodontitis. Journal of Periodontology, 2007; 78: 924 – 932.
  38. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus. Journal of Immunology, 2007, 179: 647 - 654.
  39. Kantarci A, Augustin P, Firatli E, Sheff MC, Hasturk H, Graves DT, Trackman PC. Apoptosis in Gingival Overgrowth Tissues Journal of Dental Research, 2007, 86: 888 - 892.
  40. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis in Vivo. Journal of Immunology, 2007, 179: 7021 - 7029.
  41. Codriansky KA, Rünger TM, Bhawan J, Kantarci A, Kissin EY. Multicentric reticulohistiocytosis: a systemic osteoclastic disease? Arthritis & Rheumatism (Arthritis Care & Research) 2008, 59: 444 – 448.
  42. Omori K, Ohira T, Uchida Y, Ayilavarapu S, Batista Jr EL, Yagi M, Iwata T, Liu H, Hasturk H, Kantarci A, Van Dyke TE. Priming of Neutrophil Oxidative Burst in Diabetes Requires Pre-assembly of the NADPH oxidase. Journal of Leukocyte Biology, 2008, 84: 292 – 301.
  43. Sebaoun J-D, Kantarci A, Turner JW, Carvalho RS, Van Dyke TE, Ferguson DJ. Modeling of Trabecular Bone and Lamina Dura Following Selective Alveolar Decortication. Journal of Periodontology 2008, 79: 1679- 1688.
  44. Shin H, Zhang Y, Jagannathan M, Hasturk H, Kantarci A, Liu H, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. B cells from periodontal disease patients express surface Toll-like receptor 4. Journal of Leukocyte Biology 2009, 85: 648-655.
  45. Toker H, Ozdemir H, Ozan F, Turgut M, Goze F, Sencan M, Kantarci A. Dramatic oral findings belonging to a pica patient: a case report. International Dental Journal 2009; 59: 26-30.
  46. Hasturk H, Goguet-Surmenian E, Blackwood A, Andry C, Kantarci A.1-Tetradecanol Complex: Therapeutic Actions in Experimental Periodontitis. Journal of Periodontology, 2009, 80: 1103 - 1013.
  47. Iwata T, Kantarci A, Yagi M, Jackson T, Hasturk H, Kurihara H, Van Dyke TE. Ceruloplasmin Induces PMN Priming in LAP. Journal of Periodontology, 2009; 80: 1300-1306.
  48. Noronha AM, Liang YM, Hetzel J, Hasturk H, Kantarci A, Stucchi A, Zhang Y, Nikolajczyk B, Farraye F, Ganley-Leal LM. Hyper-activated B cells in human inflammatory bowel disease Journal of Leukocyte Biology 2009; 86: 1007-1016.
  49. Yagi M, Kantarci A, Iwata T, Omori K, Ayilavarapu S, Ito K, Hasturk H, Van Dyke TE. PDK1 regulates chemotaxis in human neutrophils. Journal of Dental Research, 2009; 88: 1119-1124.
  50. Jagannathan M, Hasturk H, Liang Y-M, Shin H, Hetzel J, Kantarci A, Rubin D, McDonnell ME, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like Receptor cross talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients.  Journal of Immunology 2009; 183: 7461-7470.
  51. Baser U, Cekici A, Tanrikulu-Kucuk S, Kantarci A, Ademoglu E, Yalcin F. Gingival inflammation and interleukin 1 beta and tumor necrosis factor alpha levels in gingival crevicular fluid during menstrual  cycle. Journal of Periodontology, 2009; 80: 1983 - 1990.
  52. Ayilavarapu S, Kantarci A, Fredman G, Turkoglu O, Omori K, Liu H-S, Iwata T, Yagi M, Hasturk H, Van Dyke TE. Diabetes-induced Oxidative Stress is mediated by iPLA2 in Neutrophils. Journal of Immunology 2010; 184: 1507-1515.
  53. Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, Kantarci A, Van Dyke TE, Ganley-Leal LM, Nikolajczyk BS. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010; 53: 1461-1471.
  54. Zawawi KH, Kantarci A, Schulze-Späte U, Fujita T, Batista Jr., EL, Amar S, Van Dyke TE. Moesin-induced signaling in response to lipopolysaccharide in macrophages. Journal of Periodontal Research 2010; 45: 589 - 601.
  55. Cifcibasi-Yek E, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of Amoxicillin and Metronidazole Combination for the Management of Generalized Aggressive Periodontitis. Journal of Periodontology 2010; 81: 964 - 974.
  56. Sume SS, Kantarci A, Lee A, Hasturk H, Trackman PC. Epithelial to Mesenchymal Transition in Gingival Overgrowth. American Journal of Pathology 2010; 177: 208 - 218.
  57. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, Hasturk H, Van Dyke TE. Adjunctive Treatment of Chronic Periodontitis with Daily Dietary Supplementation with Omega-3 Fatty Acids and Low-Dose Aspirin. Journal of Periodontology 2010; 81: 1635 - 1643.
  58. Shaik-Dasthagirisaheb Yazdani B, Kantarci A, Gibson FC. Immune response of macrophages from young and aged mice to the oral pathogenic bacterium Porphyromonas gingivalis Immunity & Ageing 2010; 7: 15.
  59. Liang YM, Hasturk H, Elliot J, Noronha A, Wetzler, Kantarci A, Winter H, Farraye FA, Ganley-Leal LM. Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells.  Clinical Immunology 2011; 138: 33 - 40.
  60. Emingil G, Gurkan A, Atilla G, Kantarci A. Subantimicrobial-dose doxycyline and cytokine/chemokine levels in gingival crevicular fluid. Journal of Periodontology 2011; 82: 452 - 461
  61. Baloul SS, Gerstenfeld LC, Morgan EF, Carvalho RS, Van Dyke TE, Kantarci A. Mechanism of Action and Morphological Changes in the Alveolar Bone in Response to Selective Alveolar Decortication Facilitated Tooth Movement. Am J Orthod Dentofacial Orthop 2011; 139(4 Suppl): S83 - S101
  62. Capelli Jr, J, Kantarci A, Haffajee A, Teles RP, Fidel Jr, R, Figueredo CM. Matrix metalloproteinases and chemokines in the gingival crevicular fluid during orthodontic tooth movement. Eur J Orthodont 2011; 33: 705 - 711.
  63. Hasturk H, Kantarci A, Ghattas M, Schmidt M, Giordano R, Diekwisch T, Van Dyke TE. The Use of Light/Chemically-Hardened Poly-Methyl-Methacrylate, Poly-Hydroxyl-Ethyl-Methacrylate and Calcium Hydroxide Graft Material in Combination with Polyanhydride around Implants in Minipigs: Part I: Immediate Stability and Function Journal of Periodontology 2011; 82: 1339 - 1352.
  64. Kantarci A, Nseir Z, Kim Y-S, Sume SS, Trackman PC. Loss of Basement Membrane Integrity in Human Gingival Overgrowth. Journal of Dental Research 2011; 90: 887 – 893.
  65. Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Frontiers in Oral Biology 2012: 15: 160 – 176.
  66. Hasturk H, Kantarci A, Van Dyke TE. Oral inflammatory diseases and systemic inflammation: role of the macrophage. Frontiers in Immunology 2012: 3: 118.
  67. Saglam M, Kantarci A, Dundar N, Hakki SS. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: A Randomized, Controlled Clinical Trial. Lasers in Medical Science 2012; Nov 16
  68. Yao M, Hasturk H, Kantarci A, Gu G, Garcia-Lavin S, Fabbi M, Hayashi H, Park N, Attala K, French M, Driver V. A Pilot Study Evaluating Noncontact Low Frequency Ultrasound (NCLF-US) on Diabetic Foot Ulcers and Underlying Molecular Mechanism. International Wound Journal 2012; Nov 19.
  69. Berker E, Kantarci A, Hasturk H, Van Dyke TE. Blocking Pro-inflammatory Cytokine Release Modulates Peripheral Blood Mononuclear Cell Response to Porphyromonas gingivalis. Journal of Periodontology 2013; 84: 1337 – 1345.
  70. Cugini C, Stephens D, Nguyen D, Kantarci A, Davey ME. Arginine Deiminase Inhibits P. Gingivalis Surface Attachment. Microbiology 2013; 159 (Pt. 2): 275-285.
  71. Tonetti MS, Van Dyke TE; Working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.  Journal of Clinical Periodontology 2013; 40 Suppl 14: S24 - S29.
  72. Tonetti MS, Van Dyke TE; Working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.  Journal of Periodontology 2013; 84 (4 Suppl: S 24 – S29
  73. Browne, RW, Kantarci A, LaMonte MJ, Andrews CA, Hovey KM, Falkner KL, Cekici A, Stephens D, Genco RJ, Scannapieco FA, Van Dyke TE, Wactawski-Wende J. Performance of Multiplex Cytokine Assays in Serum and Saliva Among Community-Dwelling Postmenopausal Women. PLOS One 2013; 8: e59498
  74. Gao A, Kantarci A, Herrera B, Gao H, Van Dyke TE. A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts. PeerJ 2013; 1: e51
  75. Koyuncuoglu CZ, Calisir K, Minoglu-Saylan I, Yassibag Z, Metin S, Tuncer O, Kantarci A. Implant Supported Full-Mouth Restoration in a Young Patient with Generalized Aggressive Periodontitis. J Oral Implantology 2013, epub
  76. Kau CH, Kantarci A, Shaughnessy T, Vachiramon A, Santiwong P, da la Fuente A, Skrenes D, Ma D, Brawn P. Photobiomodulation accelerates orthodontic alignment in the early phase of treatment. Progress in Orthodontics 2013; 14: 30
  77. Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan CN, Kantarci A, Van Dyke TE. Resolvin D1 Protects Periodontal Ligament American Journal of Physiology 2013; 305: C673 - 679.
  78. Driver VR, Yao M, Kantarci A, Gu G, Park N, Hasturk H. A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus. Ostomy Wound Management 2013; 59: 19 - 26.
  79. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease Periodontology 2000 2014; 64: 57-80.
  80. Zenobia C, Hasturk H, Nguyen D, Van Dyke TE, Kantarci A, Darveau RP. Lipid A Structure is critical for establishing dysbiotic dental plaque communities in the rabbit ligature model. Infection and Immunity 2014; 82: 650 - 659.
  81. Steffens JP, Herrera BS, Coimbra LS, Rossa C, Spolidorio LC, Kantarci A, Van Dyke TE. Testosterone regulates bone response to inflammation Hormone and Metabolic Research; 2014; 46: 193 - 200.
  82. Scarparo RK, Dondoni L, Böttcher DE, Grecca FS, Figueiredo JA, Kantarci A, Van Dyke TE, Batista EL Jr. Intracanal Delivery of Resolvin E1 Controls Inflammation in Necrotic Immature Rat Teeth. Journal of Endodontics. 2014; 40(5): 678 - 682.
  83. Hasturk H, Kantarci A, Ghattas M, Schmidt M, Nguyen D, Abdallah R, Diekwisch TG, Ashman A,  Van Dyke TE. The Use of Light/Chemically-Hardened Poly-Methyl-Methacrylate, Poly-Hydroxyl-Ethyl-Methacrylate and Calcium Hydroxide Graft Material in Combination with Polyanhydride around Implants and Extraction Sockets in Minipigs: Part II: Histological and µCT Evaluations Journal of Periodontology 2014; 85 (9): 1230 – 1239.
  84. Goodson JM, Kantarci A, Hartman M-L, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F. Metabolic Disease Risk in Children by Salivary Biomarker Analysis. PlOS One 2014, 9 (6): e98799
  85. Martin CR, Zaman MM, Gilkey C, Hasturk H, Kantarci A, Van Dyke TE, Freedman SD. Resolvin D1 and Lipoxin A4 Improve Alveolarization and Normalize Septal Wall Thickness in a Neonatal Murine Model of Hyperoxia Induced Lung Injury. Metabolic Disease Risk in Children by Salivary Biomarker Analysis. PlOS One 2014, 9 (6): e98773.
  86. Dibart S, Yee C, Surmenian J, Sebaoun JD, Baloul S, Goguet-Surmenian E, Kantarci A Tissue Response during Piezocision -Assisted Tooth Movement: A Histological Study in Rats European Journal of Orthodontics 2014; 36 (4): 457 – 464.
  87. Batista EL Jr, Kantarci A, Hasturk H, Van Dyke TE.Alternative Splicing Generates a Diacylglycerol Kinase α (DGKα) Transcript That Acts as a Dominant Negative Modulator of Superoxide Production in Localized Aggressive Periodontitis. J Periodontology 2014, 85: 934 – 943.
  88. Dondoni L, Scarparo RK, Kantarci A, Van Dyke TE, Figueiredo JA, Batista Jr EL. Effect of the pro-resolution lipid mediator Resolvin E1 (RvE1) on pulp tissues exposed to the oral environment. International Endodontics Journal 2014; 47: 827 – 834.
  89. Koyuncuoglu C, Metin S, Calisir K, Minoglu-Saylan I, Tuncer O, Kantarci A. Full-Mouth Rehabilitation of a Patient with Ectodermal Dysplasia Patient with Dental Implants. Journal of Oral Implantology 2014; 40: 714-721.
  90. Haytural O, Yaman D, Ural EC, Kantarci A, Demirel K. Impact of periodontitis on chemokines in smokers. Clinical Oral Investigations 2014 Sep 6 [Epub ahead of print]
  91. Sakallioglu U, Sakallioglu EE, Lutfioglu M, Pamuk F, Kantarci A. Vascular Endothelial Cadherin and Vascular Endothelial Growth Factor in Periodontitis and Smoking. Oral Diseases 2015; 21: 263 – 269.
  92. Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE. Impact of Resolvin E1 on Murine Neutrophil Phagocytosis in Type 2 Diabetes. Infection and Immunity 2015; 83: 792-801
  93. Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, Serhan CN. Proresolving Nanomedicines Activate Bone Regeneration in Periodontitis. J Dent Res. 2015; 94: 148-156.
  94. Ayilavarapu S, Kantarci A, Hasturk H, Van Dyke TE. iPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis. J Int Acad Periodontol. 2014; 16: 121 - 126.
  95. Kantarci A, Hasturk H, Van Dyke TE. Animals models for periodontal regeneration and peri-implant responses. Periodontology 2000 2015, 68: 66 - 82.
  96. Trackman PC, Kantarci A. Molecular and Clinical Aspects of Drug-Induced Gingival Overgrowth. Journal of Dental Research 2015; 94: 540 - 546
  97. Cifcibasi E, Kantarci A, Badur S, Issever H, Cintan S. Impact of metronidazole and amoxicillin combination on matrix metalloproteinases-1 and tissue inhibitors of matrix metalloproteinases balance in generalized aggressive periodontitis. Eur J Dent. 2015; 9: 53 - 59.
  98. Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis. Arterioscler Thromb Vasc Biol. 2015; 35: 1123 – 1133
  99. Assaggaf MA, Kantarci A, Sume SS, Trackman PC. Prevention of Phenytoin-Induced Gingival Overgrowth by Lovastatin in Mice. Am J Pathol. 2015 Apr 2. pii: S0002-9440(15)00136-4
  100. Kurgan S, Önder C, Altıngöz M, Bağış N, Uyanık M, Serdar MA, Kantarcı A. High Sensitivity Detection of Salivary 8-OHdG Levels in Patients with Chronic Periodontitis. Journal of Periodontal Research 2015, 50: 766 - 774.
  101. Matsui A, Stephens D, Kantarci A, Rittling SR. Early cytokine response to infection with pathogenic vs non-pathogenic organisms in a mouse model of endodontic infection. PlOS One 2015; 10: e0132752.
  102. Herrera BS, Kantarci A, Zarrough A, Hasturk H, Leung KP, Van Dyke TE. LXA4 Actions Direct Fibroblast Function and Wound Closure. Biochem Biophys Res Commun. 2015
  103. Hasturk H, Kantarci A. Activation and resolution of periodontal inflammation and its systemic impact. Periodontology 2000 2015; 69: 255-273.
  104. Maekawa T, Hosur K, Abe T, Kantarci A, Ziogas A, Wang B, Van Dyke TE, Chavakis T, Hajishengallis G. IL-17 downregulates endothelial cell expression of the homeostatic factor Del-1 through a GSK-3β–C/EBPβ pathway: reversal by D-series resolvins  Nature Communications 2015; 6 : 8272
  105. Steffens JP, Coimbra LS, Rossa C Jr, Kantarci A, Van Dyke TE, Spolidorio LC. Androgen receptors and experimental bone loss - an in vivo and in vitro study. Bone. 2015; 81: 683-690.
  106. Steffens JP, Wang X, Starr JR, Spolidorio LC, Van Dyke TE, Kantarci A. Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III. Journal of Periodontology 2015; 86: 1116-1125.
  107. Eren G, Kantarci A, Sculean A, Atilla G. Vascularization after treatment of gingival recession defects with platelet-rich fibrin or connective tissue graft. Clin Oral Investig. 2016; Nov;20(8):2045-2053
  108. Shaughnessy T, Kantarci A, Kau CH, Skrenes D, Skrenes S, Ma D. Intraoral photobiomodulation-induced orthodontic tooth alignment: a preliminary study. BMC Oral Health. 2016 Jan 13; 16(1):3.
  109. Pamuk F, Cetinkaya BO, Keles GC, Balli U, Koyuncuoglu CZ, Cintan S, Kantarci A. A novel blood stopper enhances healing after osseus grafting in patients with intrabony periodontal defects. Journal of Periodontal Research 2016; 51(4):540-7.
  110. Özcan E, Saygun NI, Serdar MA, Bengi VU, Kantarcı A. Non-Surgical Periodontal Therapy Reduces Saliva Adipokines and Matrix Metalloproteinases Levels in Periodontitis. J Periodontol. 2016 Mar 18:1-13
  111. Konermann A, Kantarci A, Wilbert S, Van Dyke T, Jäger A. Verification of γ-Amino-Butyric Acid (GABA) Signaling System Components in Periodontal Ligament Cells In Vivo and In Vitro. Cell Mol Neurobiol. 2016 Nov;36(8):1353-1363.
  112. Papathanasiou E, Kantarci A, Konstantinidis A, Gao H, Van Dyke TE.  SOCS-3 Regulates Alveolar Bone Loss in Experimental Periodontitis. J Dent Res. 2016; 95: 1018-1025.
  113. Öncü E, Bayram B, Kantarci A, Gülsever S, Alaaddinoğlu EE. Positive effect of platelet rich fibrin on osseointegration. Med Oral Patol Oral Cir Bucal. 2016 Sep 1; 21(5): e601-7
  114. Papadopoulos G, Shaik-Dasthagirisaheb YB, Huang N, Viglianti GA, Henderson AJ, Kantarci A, Gibson FC 3rd. Immunologic environment influences macrophage response to Porphyromonas gingivalis. Mol Oral Microbiol. 2016 Jun 27
  115. Mendes RT, Nguyen D, Stephens D, Pamuk F, Fernandes D , Van Dyke TE, Kantarci A. Endothelial Cell response to Fusobacterium nucleatum. Infection and Immunity 2016; 84: 2141-2148.
  116. Lee CT, Teles R, Kantarci A, Chen T, McCafferty J, Starr JR, Brito LC, Paster BJ, Van Dyke TE. Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. J Immunol. 2016 Oct 1;197(7):2796-806
  117. Kurgan S, Kansal S, Nguyen D, Stephens D, Koroneos Y, Hasturk H, Van Dyke TE, Kantarci A. Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function. J Periodontol 2016 Oct 20:1-17
  118. Konermann A, Van Dyke T, Kantarci A, Jäger A. GABAB Receptors as Modulating Target for Inflammatory Responses of the Periodontal Ligament. Cell Mol Neurobiol. 2016 Nov 3
  119. Önder C, Kurgan Ş, Altıngöz SM, Bağış N, Uyanık M, Serdar MA, Kantarci A, Günhan M. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress. Clin Oral Investig. 2016 Nov 2
  120. Damgaard C, Kantarci A, Holmstrup P, Hasturk H, Nielsen CH, Van Dyke TE. Porphyromonas gingivalis-induced production of reactive oxygen species, tumor necrosis factor-α, interleukin-6, CXCL8 and CCL2 by neutrophils from localized aggressive periodontitis and healthy donors: modulating actions of red blood cells and resolvin E1. J Periodontal Res. 2017 Apr;52(2):246-254.
  121. Bozkurt SB, Hakki SS, Hakki EE, Durak Y, Kantarci A. Porphyromonas gingivalis Lipopolysaccharide Induces a Pro-inflammatory Human Gingival Fibroblast Phenotype. Inflammation. 2017; 40 (1): 144- 153
  122. Keskiner I, Saygun I, Bal V, Serdar M, Kantarci A. Dietary supplementation with low-dose omega-3 fatty acids reduces salivary tumor necrosis factor-α levels in patients with chronic periodontitis: a randomized controlled clinical study. J Periodontal Res. 2017 Feb 8.
  123. Tunçer NI, Arman-Özçirpici A, Oduncuoglu BF, Göçmen JS, Kantarci A. Efficiency of piezosurgery technique in miniscrew supported en-masse retraction: a single-centre, randomized controlled trial. Eur J Orthod. 2017 Apr 11
  124. Santana L, Motro M, Bamashmous MS, Kantarci A, Will LA. Buccolingual angulation and intermolar width changes in the maxillary first molars of untreated growing children. Am J Orthod Dentofacial Orthop. 2017 May;151(5):921-928
  125. Nashef A, Abu-Toamih Atamni HJ, Buchnik Y, Hasturk H, Kantarci A, Stephens D, Wiess EI, Houri-Haddad Y, Iraqi FA. Collaborative Cross Mouse Population for Studying the Alveolar Bone Changes and Impaired Glucose Tolerance Comorbidity After High Fat Diet Consumption. J Periodontol 2017 May 19:1-14.
  126. Kantarci A, Hasturk H. Microbes and Host Response: A relationship in health and disease. Oral Diseases 2017 Aug 11
  127. Medeiros RB, Pires FR, Kantarci A, Capelli J Jr. Tissue repair after selective alveolar corticotomy in orthodontic patients: A preliminary study. Angle Orthod. 2017 Nov 13
  128. Manosudprasit A, Kantarci A, Hasturk H, Stephens D, Van Dyke TE. Spontaneous PMN apoptosis in type 2 diabetes and the impact of periodontitis. J Leukoc Biol. 2017; 102: 1431-1440
  129. Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep. 2017; 19(12): 57
  130. Kantarci A, Aytan N, Palaska I, Stephens D, Crabtree L, Benincasa C, Jenkins BG, Carreras I, Dedeoglu A. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease. Exp Neurol. 2018 Feb; 300: 111-120.
  131. Tunçer Nİ, Arman-Özçırpıcı A, Oduncuoğlu BF, Kantarci A. Osseous outgrowth on the buccal maxilla associated with piezosurgery-assisted en-masse retraction: A case series. Korean J Orthod. 2018 Jan;48(1):57-62
  132. Kurgan S, Kantarci A. Molecular Basis for Immunohistochemical and Inflammatory Changes during Progression of Gingivitis to Periodontitis. Periodontol 2000 2018; 76: 51-67
  133. Jepsen S, Caton JG, Albandar JM, Bissada NF, Bouchard P, Cortellini P, Demirel K, de Sanctis M, Ercoli C, Fan J, Geurs NC, Hughes FJ, Jin L, Kantarci A, Lalla E, Madianos PN, Matthews D, McGuire MK, Mills MP, Preshaw PM, Reynolds MA, Sculean A, Susin C, West NX, Yamazaki K.  Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1: S237-S248

Jepsen S, Caton JG, Albandar JM, Bissada NF, Bouchard P, Cortellini P, Demirel K, de Sanctis M, Ercoli C, Fan J, Geurs NC, Hughes FJ, Jin L, Kantarci A, Lalla E, Madianos PN, Matthews D, McGuire MK, Mills MP, Preshaw PM, Reynolds MA, Sculean A, Susin C, West NX, Yamazaki K. Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018 Jun;45 Suppl 20: S219-S229

  1. Saxena D, Mahjour F, Findlay AD, Mously EA, Kantarci A, Trackman PC. Multiple Functions of Lysyl Oxidase Like-2 in Oral Fibroproliferative Processes. J Dent Res. 2018 May 1:22034518775971
  2. Steffens JP, Santana LCL, Pitombo JCP, Ribeiro DO, Albaricci MCC, Warnavin SVSC, Kantarci A, Spolidorio LC. The role of androgens on periodontal repair in female rats. J Periodontol. 2018 Apr;89(4):486-495.
  3. Finn SC, Silver MT, Canary B, Kantarci A, Allareddy V, Katebi N, Masoud MI. A Modified steiner's analysis that does not require radiographic exposure of the cranial base. Orthod Craniofac Res. 2018 Oct 26.
  4. Yavuz MC, Sunar O, Buyuk SK, Kantarci A. Comparison of piezocision and discision methods in orthodontic treatment. Prog Orthod. 2018 Oct 29;19(1):44.
  5. Hersberger-Zurfluh MA, Papageorgiou SN, Motro M, Kantarci A, Will LA, Eliades T. Facial soft tissue growth in identical twins. Am J Orthod Dentofacial Orthop. 2018 Nov;154(5):683-692.
  6. Mendes RT, Nguyen D, Stephens D, Pamuk F, Fernandes D, Hasturk H, Van Dyke TE, Kantarci A. Hypoxia-induced endothelial cell responses - possible roles during periodontal disease. Clin Exp Dent Res. 2018 Dec 14;4(6):241-248. PMID: 30603105
  7. Tayman MA, Kurgan Ş, Önder C, Güney Z, Serdar MA, Kantarcı A, Günhan M. A disintegrin-like and metalloproteinase with thrombospondin-1 (ADAMTS-1) levels in gingival crevicular fluid correlate with vascular endothelial growth factor-A, hypoxia-inducible factor-1α, and clinical parameters in patients with advanced periodontitis. J Periodontol. 2019 Apr 25
  8. Mahjour F, Dambal V, Shrestha N, Singh V, Noonan V, Kantarci A, Trackman PC. Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB. Oncogenesis. 2019 May 13;8(5):34
  9. Bartold PM, Kantarci A, Feres M, Iacono VJ, Meyle J. Meeting report 1st International Academy of Periodontology Research Conference (IAPRC). Int Dent J. 2019 May 24. doi: 10.1111/idj.1248
  10. Feres M, Kantarci A, Genco RJ, Papapanou PN, Giannobile WV. Ricardo Teles: His Life and Contributions to Periodontology. J Dent Res. 2019 Jul;98(7):734-738
  11. Alvarez C, Monasterio G, Cavalla F, Córdova LA, Hernández M, Heymann D, Garlet GP, Sorsa T, Pärnänen P, Lee HM, Golub LM, Vernal R, Kantarci A. Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms. Front Immunol. 2019 Jul 18; 10: 1664.
  12. Steffens JP, Valenga HM, Santana LCL, Albaricci MCDC, Kantarci A, Spolidorio LC. Role of testosterone and androgen receptor in periodontal disease progression in female rats. J Periodontol. 2019 Aug 7.
  13. Martinez PJ, Farhan A, Mustafa M, Javaid N, Darkoh C, Garrido-Sanabria E, Fisher-Hoch SP, Briles DE, Kantarci A, Mirza S. PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs) Microb Pathog. 2019 Aug 6; 136: 103653.
  14. Sani ES, Lara RP, Aldawood Z, Bassir SH, Nguyen D, Kantarci A, Intini G, Annabi N. An Antimicrobial Dental Light Curable Bioadhesive Hydrogel for Treatment of Peri-Implant Diseases. Matter. 2019 Oct 2;1(4):926-944.
  15. Hersberger-Zurfluh MA, Papageorgiou SN, Motro M, Kantarci A, Will LA, Eliades T. Vertical growth in mono- and dizygotic twins: A longitudinal cephalometric cohort study. Orthod Craniofac Res. 2019 Nov 19
  16. Küçük D, Savran L, Ercan UK, Yarali ZB, Karaman O, Kantarci A, Sağlam M, Köseoğlu S. Evaluation of efficacy of non-thermal atmospheric pressure plasma in treatment of periodontitis: a randomized controlled clinical trial. Clin Oral Investig. 2020 Jan 2.
  17. Castro Dos Santos NC, Andere NM, Araujo CF, de Marco AC, Kantarci A, Van Dyke TE, Santamaria MP. J Periodontol. Omega-3 PUFA and Aspirin as Adjuncts to Periodontal Debridement in Patients with Periodontitis and Type 2 Diabetes Mellitus. Randomized Clinical Trial 2020 Feb 26. doi: 10.1002/JPER.19-0613
  18. Albuquerque-Souza E, Schulte F, Chen T, Hardt M, Hasturk H, Van Dyke TE, Holzhausen M, Kantarci A. Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions. Front Immunol. 2020 Sep 25;11:585530. doi: 10.3389/fimmu.2020.585530. eCollection 2020.
  19. Kantarci A, Tognoni CM, Yaghmoor W, Marghalani A, Stephens D, Ahn JY, Carreras I, Dedeoglu A. Microglial response to experimental periodontitis in a murine model of Alzheimer's disease. Sci Rep. 2020 Oct 29;10(1):18561. doi: 10.1038/s41598-020-75517-4.
  20. Alvarez C, Suliman S, Almarhoumi R, Vega ME, Rojas C, Monasterio G, Galindo M, Vernal R, Kantarci A. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis. Sci Rep. 2020 Nov 4;10(1):19018. doi: 10.1038/s41598-020-76038-w.
  21. Özcan E, Saygun I, Kantarci A, Özarslantürk S, Serdar MA, Özgürtaş T. The effects of a novel non-invasive application of platelet-rich fibrin on periodontal clinical parameters and gingival crevicular fluid transforming growth factor-β and collagen-1 levels: A randomized controlled clinical study.  J Periodontol. 2021 Sep;92(9):1252-1261. doi: 10.1002/JPER.20-0713. Epub 2021 Jan 15
  22. Seubbuk S, Surarit R, Stephens D, Hasturk H, Van Dyke TE, Kantarci A. TLR2 and TLR4 Differentially Regulate the Osteogenic Capacity of Human Periodontal Ligament Fibroblasts. J Int Acad Periodontol. 2021 Jan 1;23(1):3-10.
  23. Hersberger-Zurfluh MA, Papageorgiou SN, Motro M, Kantarci A, Will LA, Eliades T. Genetic and environmental components of vertical growth in mono- and dizygotic twins up to 15-18 years of age. Angle Orthod. 2021 May 1;91(3):384-390. doi: 10.2319/060520-515.1.
  24. Cotti E, Ideo F, Pedrazzini A, Bardini G, Musu D, Kantarci A. Pro-resolving Mediators in Endodontics. A Systematic Review. J Endod. 2021 Feb 3: S0099-2399(21)00071-6. doi: 10.1016/j.joen.2021.01.008.
  25. Arvikar SL, Hasturk H, Strle K, Stephens D, Bolster MB, Collier DS, Kantarci A, Steere AC. Periodontal inflammation and distinct inflammatory profiles in saliva and GCF compared with serum and joints in rheumatoid arthritis patients. J Periodontol. 2021 Oct;92(10):1379-1391. doi: 10.1002/JPER.20-0051. Epub 2021 Mar 16. PMID: 33611834
  26. Chiu CJ, Chang ML, Kantarci A, Van Dyke TE, Shi W. Exposure to Porphyromonas gingivalis and Modifiable Risk Factors Modulate Risk for Early Diabetic Retinopathy. Transl Vis Sci Technol. 2021 Feb 5;10(2):23.
  27. Oner F, Alvarez C, Yaghmoor W, Stephens D, Hasturk H, Firatli E, Kantarci A. Resolvin E1 Regulates Th17 Function and T Cell Activation. Front Immunol. 2021 Mar 17; 12: 637983. doi: 10.3389/fimmu.2021.637983.
  28. Alvarez C, Abdalla H, Sulliman S, Rojas P, Wu YC, Almarhoumi R, Huang RY, Galindo M, Vernal R, Kantarci A. RvE1 Impacts the Gingival Inflammatory Infiltrate by Inhibiting the T Cell Response in Experimental Periodontitis. Front Immunol. 2021 May 3;12:664756. doi: 10.3389/fimmu.2021.664756.
  29. Danz JC, Kantarci A, Bornstein MM, Katsaros C, Stavropoulos A. Impact of Orthodontic Forces on Plasma Levels of Markers of Bone Turnover and Inflammation in a Rat Model of Buccal Expansion. Front Physiol. 2021 May 25;12:637606. doi: 10.3389/fphys.2021.637606.
  30. Castro dos Santos NC, Andere NMRB, Araujo CF, Retamal-Valdes B, Martinho FC, Kantarci A, Van Dyke TE, Feres M, Santamaria MP. Impact of Periodontal Therapy and Adjunctive Omega-3 plus Aspirin on Quality of Life in Patients with Periodontitis and Type 2 Diabetes. J Int Acad of Periodontol. 2021 May; 23/3: 224 - 234.
  31. Tashkandi N, Zhao Y, Mitchell-Lee G, Stephens D, Patel M, Motro M, Will LA, Kantarci A. Longitudinal assessment of salivary vitamin D binding protein during orthodontic tooth movement. BMC Oral Health. 2021 Jul 5; 21(1):332. doi: 10.1186/s12903-021-01689-8.
  32. George Hajishengallis, Hatice Hasturk, John D. Lambris, Danae A. Apatzidou, Georgios N. Belibasakis, Nagihan Bostanci, Patricia M. Corby, Christopher W. Cutler, Francesco D’Aiuto, Evlambia Hajishengallis, Markus Huber-Lang, Effie Ioannidou, Tetsuhiro Kajikawa, Alpdogan Kantarci, Jonathan M. Korostoff, Georgios A. Kotsakis, Tomoki Maekawa, Dimitrios C. Mastellos, Niki M. Moutsopoulos, Srinivas Myneni, Richard Nagelberg, Bo Nilsson, Panos N. Papapanou, Evangelos Papathanasiou, Jan Potempa, Antonio Risitano, S. Esra Sahingur, Atsushi Saito, Anton Sculean, Andreas Stavropoulos, Flavia R. Teles, Maurizio Tonetti, DespinaYancopoulou. C3-targeted therapy in periodontal disease: moving closer to the clinic. Trends in Immunology 2021 October; 42 (10), 856-864
  33. Celik D, Kantarci A.Vascular Changes and Hypoxia in Periodontal Disease as a Link to Systemic Complications. Pathogens. 2021 Oct 5;10(10):1280.
  34. Kantarci A, Stavropoulos A, Sculean A. Introduction: Vision of Regenerative Periodontology. Dent Clin North Am. 2022 Jan;66(1):xi-xiii. doi: 10.1016/j.cden.2021.08.002. Epub 2021 Oct 20. PMID: 34794557
  35. Kantarci A. Biological Basis of Periodontal Regeneration. Dent Clin North Am. 2022 Jan;66(1):1-9. doi: 10.1016/j.cden.2021.08.001. Epub 2021 Sep 8. PMID: 34794547
  36. Cosgarea R, Kantarci A, Stavropoulos A, Arweiler N, Sculean A. Soft Tissue Regeneration at Natural Teeth. Dent Clin North Am. 2022 Jan;66(1):87-101. doi: 10.1016/j.cden.2021.09.001. PMID: 3479455
  37. Stavropoulos A, Bertl K, Sculean A, Kantarci A. Regenerative Periodontal Therapy in Intrabony Defects and Long-Term Tooth Prognosis. Dent Clin North Am. 2022 Jan;66(1):103-109. doi: 10.1016/j.cden.2021.09.002. PMID: 34794548
  38. Hersberger-Zurfluh MA, Papageorgiou SN, Motro M, Kantarci A, Will LA, Eliades T. Heritability of facial soft tissue growth in mono- and dizygotic twins at 12 and 17 years of age: A retrospective cohort study. Orthod Craniofac Res 2022 Jan 11. doi: 10.1111/ocr.12565. Online ahead of print.
  39. Ma KS, Hasturk H, Carreras I, Dedeoglu A, Veeravalli JJ, Huang JY, Kantarci A, Wei JC. Dementia and the Risk of Periodontitis: A Population-Based Cohort Study. J Dent Res. J Dent Res. 2022 Mar;101(3):270-277.
  40. Gürsoy UK, Kantarci A. Molecular biomarker research in periodontology: A roadmap for translation of science to clinical assay validation. J Clin Periodontol. 2022 Mar 23. doi: 10.1111/jcpe.13617. Online ahead of print.
  41. Hatipoğlu M, Daltaban Ö, Uğur S, Üstün K, Kaçar C, Tuncer T, Kantarci A. B cell depletion in patients with rheumatoid arthritis is associated with reduced IL-1β in GCF. Clin Oral Investig. 2022 May 17. doi: 10.1007/s00784-022-04378-0. Online ahead of print
  42. Rovai ES, Alves T, Gasparoni LM, França BN, Sipert CR, Kantarci A, Holzhausen M. Protease-activated receptor type 1 (PAR1) increases CEMP1 gene expression through MAPK/ERK pathway. Braz Oral Res. 2022 Apr 15;36:e048. doi: 10.1590/1807-3107bor-2022.vol36.0048. eCollection 2022.
  43. Roberts HM, Yonel Z, Kantarci A, Grant MM, Chapple ILC. Impact of Gingivitis on Circulating Neutrophil Reactivity and Gingival Crevicular Fluid Inflammatory Proteins. Int J Environ Res Public Health. 2022 May 23;19(10):6339. doi: 10.3390/ijerph19106339.
  44. Alqaderi H, Hegazi F, Al-Mulla F, Chiu CJ, Kantarci A, Al-Ozairi E, Abu-Farha M, Bin-Hasan S, Alsumait A, Abubaker J, Devarajan S, Goodson JM, Hasturk H, Tavares M. Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in Adolescents. Front Public Health. 2022 Jun 10;10:800373. doi: 10.3389/fpubh.2022.800373. eCollection 2022.PMID: 35757631
  45. Pamuk F, Kantarci A. Inflammation as a link between periodontal disease and obesity. Periodontol 2000. 2022 Aug 2. doi: 10.1111/prd.12457.
  46. Cai J, Liu J, Yan J, Lu X, Wang X, Li S, Mustafa K, Wang H, Xue Y, Mustafa M, Kantarci A, Xing Z. Impact of Resolvin D1 on the inflammatory phenotype of periodontal ligament cell response to hypoxia. J Periodontal Res. 2022 57(5):1034-1042
  47. Kantarci A, Kansal S, Hasturk H, Stephens D, Van Dyke TE. Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer. Am J Pathol. 2022 Aug 6:S0002-9440(22)00215-2. doi: 10.1016/j.ajpath.2022.07.004.
  48. Jiang X, Liu J, Li S, Qiu Y, Wang X, He X, Pedersen TØ, Mustafa K, Xue Y, Mustafa M, Kantarci A, Xing Z. The effect of resolvin D1 on bone regeneration in a rat calvarial defect model. J Tissue Eng Regen Med. 2022 Aug 18. doi: 10.1002/term.3345. Online ahead of print.
  49. Chaaban M, Al Sulaiman A, Kantarci A, Stashenko P, Will LA, Motro M. Longitudinal changes in the dental arch width and symmetry in identical and fraternal twins. Am J Orthod Dentofacial Orthop. 2022 Sep 19: S0889-5406(22) 00468-1
  50. Zarrough AE, Hasturk H, Stephens DN, Van Dyke TE, Kantarci A. Resolvin D1 modulates periodontal ligament fibroblast function. J Periodontol. 2022 Nov 23. doi: 10.1002/JPER.22-0462. Online ahead of print.
  51. Bengi V U, Saygun I, Bal V, Ozcan E, Kose Ozkan C, Torun D, Avcu F, Kantarci A. Effect of antioxidant lycopene on human osteoblasts Clin Oral Investig. 2022 Nov 22. doi: 10.1007/s00784-022-04789-z. Online ahead of print.
  52. Abdalla HB, Alvarez C, Wu YC, Rojas P, Hammock BD, Maddipati KR, Trindade-da-Silva CA, Soares MQS, Clemente-Napimoga JT, Kantarci A, Napimoga MH, Van Dyke TE. Soluble epoxide hydrolase inhibition enhances production of specialized pro-resolving lipid mediator and promotes macrophage plasticity Br J Pharmacol. 2022 Dec 12. doi: 10.1111/bph.16009. Online ahead of print.PMID: 3650831.
  53. Kloukos D, Kalimeri E, Gkourtsogianni S, Kantarci A, Katsaros C, Stavropoulos A. Impact of fixed orthodontic appliances on blood count and high-sensitivity C-reactive protein levels: A prospective cohort study. Am J Orthod Dentofacial Orthop. 2023 Mar 18:S0889-5406(23)00107-5. doi: 10.1016/j.ajodo.2023.01.016. Online ahead of print.
  54. Chapple ILC, Hirschfeld J, Kantarci A, Wilensky A, Shapira L. The role of the host-Neutrophil biology. Periodontol 2000. 2023 May 18. doi: 10.1111/prd.12490. Online ahead of print.
  55. Ellett F, Kacamak NI, Alvarez CR, Oliveira EHS, Hasturk H, Paster BJ, Kantarci A, Irimia D. Fusobacterium nucleatum dissemination by neutrophils Journal of Oral Microbiol. 2023 Jun 4;15(1):2217067. doi: 10.1080/20002297.2023.2217067. eCollection 2023
  56. Almarhoumi R, Alvarez C, Harris T, Tognoni CM, Paster BJ, Carreras I, Dedeoglu A, Kantarci A. Microglial cell response to experimental periodontal disease. J Neuroinflammation. 2023 Jun 14;20(1):142. doi: 10.1186/s12974-023-02821
  57. Bozkurt SB, Hakki SS, Kantarci A. Differential effects of resolvin D1 and resolvin E1 on cementoblast function J Periodontol. 2023 Jun 15. doi: 10.1002/JPER.22-0510. Online ahead of print
  58. Kuzu TE, Öztürk K, Gürgan CA, Yay A, Göktepe Ö, Kantarcı A. Anti-inflammatory and pro-regenerative effects of a monoterpene glycoside on experimental periodontitis in a rat model of diabetes. J Periodontal Res. 2023 Jun 20. doi: 10.1111/jre.13151. Online ahead of print.
  59. Yilmaz M, Yay E, Balci N, Toygar H, Kılıc BB, Zirh A, Rivas CA, Kantarci A. Parkinson's disease is positively associated with periodontal inflammation. J Periodontol. 2023 Jul 11. doi: 10.1002/JPER.23-0274. Online ahead of print.
  60. Karasu YÖ, Orbak R, Kaşalı K, Berker E, Kantarci A. Association between androgenetic alopecia and periodontitis. J Periodontal Res. 2023 Aug 12. doi: 10.1111/jre.13175. Online ahead of print. PMID: 37571914
  61. Özkan Karasu Y, Orbak R, Kaşalı K, Berker E, Kantarci A. Porphyromonas gingivalis enhances the senescence-induced increase of 5-alpha reductase in gingival fibroblasts. Clin Oral Investig. 2023 Aug 22. doi: 10.1007/s00784-023-05211-y. Online ahead of print. PMID: 37608238
  62. Yay E, Yilmaz M, Toygar H, Balci N, Alvarez Rivas C, Bolluk Kilic B, Zirh A, Paster B, Kantarci A. Parkinson's disease alters the composition of subgingival microbiome J Oral Microbiol. 2023 Aug 28;15(1):2250650. doi: 10.1080/20002297.2023.2250650. eCollection 2023.PMID: 37649970
  63. Pamuk F, Lütfioğlu M, Paksoy T, Koyuncuoglu CZ, Polat NG, Cifcibasi E, Yildirim S, Kantarci A. Impact of low-level laser therapy as an adjunct to non-surgical periodontal treatment on the levels of tissue plasminogen activator and plasminogen activator inhibitor 1 in Stage 3-4, Grade C periodontitis patients: a split-mouth, randomized control study Clin Oral Investig. 2023 Sep 15. doi: 10.1007/s00784-023-05248-z.
  64. Güney Z, Kurgan Ş, Önder C, Tayman MA, Günhan Ö, Kantarci A, Serdar MA, Günhan M. Wnt signaling in Periodontitis. Clin Oral Investig. 2023 Oct 10. doi: 10.1007/s00784-023-05294-7. Online ahead of print.PMID: 37814163
  65. Wu YC, Yu N, Rivas CA, Mehrnia N, Kantarci A, Van Dyke TE. RvE1 Promotes Axin2+ Cell Regeneration and Reduces Bacterial Invasion. J Dent Res. 2023 Oct 13:220345231197156. doi: 10.1177/00220345231197156. Online ahead of print.
  66. Andriankaja OM, Adatorwovor R, Kantarci A, Hasturk H, Shaddox L, Levine MA. Periodontal Disease, Local and Systemic Inflammation in Puerto Ricans with Type 2 Diabetes Mellitus Biomedicines. 2023 Oct 12;11(10):2770. doi: 10.3390/biomedicines11102770.
  67. Yang Y, Alves T, Miao MZ, Wu YC, Li G, Lou J, Hasturk H, Van Dyke TE, Kantarci A, Wu D. Single-Cell Transcriptomic Analysis of Dental Pulp and Periodontal Ligament Stem Cells. J Dent Res. 2023 Nov 20:220345231205283. doi: 10.1177/00220345231205283. PMID: 37982164
  68. Hersberger-Zurfluh MA, Motro M, Kantarci A, Will LA, Eliades T, Papageorgiou SN. Genetic and environmental impact on mandibular growth in mono- and dizygotic twins during adolescence: A retrospective cohort study. Int Orthod. 2024 Jan 12;22(1):100842. doi: 10.1016/j.ortho.2023.100842. Online ahead of print. PMID: 38217936
  69. Abdalla HB, Puhl L, Rivas CA, Wu YC, Rojas P, Trindade-da-Silva CA, Hammock BD, Maddipati KR, Soares MQS, Clemente-Napimoga JT, Kantarci A, Napimoga MH, Van Dyke TE. Modulating the sEH/EETs Axis Restrains Specialized Proresolving Mediator Impairment and Regulates T Cell Imbalance in Experimental Periodontitis. J Immunol. 2024 Feb 1;212(3):433-445. doi: 10.4049/jimmunol.2300650. PMID: 38117781
  70. Yay E, Yilmaz M, Toygar H, Balci N, Alvarez Rivas C, Bolluk Kılıç B, Zirh A, Paster BJ, Kantarci A. Oral and gut microbial profiling in periodontitis and Parkinson's disease. J Oral Microbiol. 2024 Mar 21;16(1):2331264. doi: 10.1080/20002297.2024.2331264. eCollection 2024.
  71. Özkan Karasu Y, Öner F, Kantarci A. Neutrophil response to Porphyromonas gingivalis is modulated by low-level laser application. Oral Dis. 2024 Apr 9. doi: 10.1111/odi.14954. Online ahead of print.
  72. Unlu O, Demirci M, Paksoy T, Eden AB, Tansuker HD, Dalmizrak A, Aktan C, Senel F, Sunter AV, Yigit O, Cakir BO, Kantarci A. Oral microbial dysbiosis in patients with oral cavity cancers. Clin Oral Investig. 2024 Jun 17;28(7):377. doi: 10.1007/s00784-024-05770-8
  73. Tubero Euzebio Alves V, Alves T, Silva Rovai E, Hasturk H, Van Dyke T, Holzhausen M, Kantarci A. Arginine-specific gingipains (RgpA/RgpB) knockdown modulates neutrophil machinery. J Oral Microbiol. 2024 Jul 9;16(1):2376462. doi: 10.1080/20002297.2024.2376462. eCollection 2024.
  74. Suárez LJ, Hasturk H, Tubero Euzebio Alves V, Díaz-Baez D, Van Dyke T, Kantarci A. Overexpression of the receptor for resolvin E1 (ERV1) prevents early alveolar bone loss in leptin receptor deficiency-induced diabetes. J Periodontol. 2024 Jun 21. doi: 10.1002/JPER.24-0060. Online ahead of print.PMID: 39031577
  75. Yakar N, Yilmaz B, Emingil G, Chen T, Ozdemir G, Kantarci A. Subgingival microbial profiles in pre- and postmenopausal women: Associations with serum estradiol levels. J Periodontol. 2024 Jul 14. doi: 10.1002/JPER.24-0267. Online ahead of print. PMID: 39003582
  76. Slezovic MÖ, Saygun I, Bengi VU, Serdar M, Kantarci A. Antiproliferative effect of low-level laser/ photobiomodulation on gingival fibroblasts derived from calcium channel blocker-induced gingival overgrowth. Lasers Med Sci. 2024 Jul 25;39(1):194. doi: 10.1007/s10103-024-04122-y. PMID: 3905207
  77. Saygun I, Slezovic MÖ, Özkan CK, Bengi VU, Elçi P, Serdar M, Kantarci A. Anti-proliferative impact of resveratrol on gingival fibroblasts from juvenile hyaline fibromatosis. Clin Oral Investig. 2024 Jul 26;28(8):448. doi: 10.1007/s00784-024-05771-7. PMID: 39060456
  78. Teles FRF, Chandrasekaran G, Martin L, Patel M, Kallan MJ, Furquim C, Hamza T, Cucchiara AJ, Kantarci A, Urquhart O, Sugai J, Giannobile WV. Salivary and serum inflammatory biomarkers during periodontitis progression and after treatment. J Clin Periodontol. 2024 Aug 5. doi: 10.1111/jcpe.14048. Online ahead of print. PMID: 39104016
  79. Yakar N, Unlu O, Cen L, Hasturk H, Chen T, Shi W, He X, Kantarci A. Targeted elimination of Fusobacterium nucleatum alleviates periodontitis. J Oral Microbiol. 2024 Aug 12;16(1):2388900. doi: 10.1080/20002297.2024.2388900. eCollection 2024. PMID: 39139835
  80. Yılmaz B, Emingil G, Öztürk VÖ, Atmaca H, Köse T, Kantarci A. Gingival crevicular fluid levels of TLR-9, AIM-2, and ZBP-1 in periodontal diseases Oral Dis. 2024 Aug 22. doi: 10.1111/odi.15108.
  81. Tezcan G, Yakar N, Hasturk H, Van Dyke TE, Kantarci A. Resolution of chronic inflammation and cancer. Periodontol 2000. 2024 Aug 23. doi: 10.1111/prd.12603.
  82. Teles F, Martin L, Patel M, Hu W, Bittinger K, Kallan MJ, Chandrasekaran G, Cucchiara AJ, Giannobile WV, Stephens D, Kantarci A. Gingival Crevicular Fluid Biomarkers During Periodontitis Progression and After Periodontal Treatment J Clin Periodontol. 2024 Sep 15. doi: 10.1111/jcpe.14061
  83. Sahinkaya S, Yilmaz M, Yay E, Toygar H, Balci N, Altinisik DD, Kutlubay Z, Kantarci A. Behçet's disease modifies the gingival inflammatory response. J Periodontol. 2024 Sep 19. doi: 10.1002/JPER.24-0182.
  84. Santos NCCD, Cotrim KC, Achôa GL, Kalil EC, Kantarci A, Bueno DF. The Use of Mesenchymal Stromal/Stem Cells (MSC) for Periodontal and Peri-implant Regeneration: Scoping Review Braz Dent J. 2024 Oct 25;35:e246134. doi: 10.1590/0103-6440202406134. eCollection 2024.PMID: 39476117
  85. Mizgier ML, Nardocci G, Ramírez V, Bendek MJ, Hernández M, Rojas C, Herrera D, Kantarci A, Kemp MW, Illanes SE, Chaparro A. Proteomic Insights Into Gingival Crevicular Extracellular Vesicles in Periodontitis and Gestational Diabetes: An Exploratory Study. J Clin Periodontol. 2024 Nov 12. doi: 10.1111/jcpe.14083. Online ahead of print.PMID: 39532703
  86. Teles FRF, Chandrasekaran G, Martin L, Patel M, Kallan MJ, Furquim C, Hamza T, Cucchiara AJ, Kantarci A, Urquhart O, Sugai J, Giannobile WV. Salivary and serum inflammatory biomarkers during periodontitis progression and after treatment. J Clin Periodontol. 2024 Dec;51(12):1619-1631. doi: 10.1111/jcpe.14048. Epub 2024 Aug 5. PMID: 39104016
  87. Oner F, Kantarci A. Periodontal response to nonsurgical accelerated orthodontic tooth movement. Periodontol 2000. 2025 Jan 22. doi: 10.1111/prd.12623. Online ahead of print. PMID: 39840535
  88. Xing Z, Liu J, Cai J, Jiang X, Liang J, Fujio M, Hadler-Olsen E, Wang J, Kantarci A, Xue Y. The Application of Resolvin D1-Loaded Gelatin Methacrylate in a Rat Periodontitis Model Pharmaceutics. 2024 Dec 25;17(1):16. doi:10.3390/pharmaceutics17010016. PMID: 39861667
  89. Al-Obaidi S, Papageorgiou SN, Saade M, Caradonna KM, Kantarci A, Will L, Motro M. Influence of genetic and environmental factors on transverse growth Eur J Orthod. 2025 Feb 7;47(2):cjaf003. doi: 10.1093/ejo/cjaf003.PMID: 39963946
  90. Dönmez MF, Balci N, Sunkar AE, Toygar H, Kantarci A. Taurine levels in periodontitis: A pilot study. J Periodontol. 2025 Mar 28. doi: 10.1002/JPER.24-0574. Online ahead of print.PMID: 40153370

 

Book Chapters

  1. Laboratory Techniques for the Analysis of Microbial Etiological Factors and Host Response in Periodontal Disease. Mutlu, S., Cebeci, İ., Kantarci, A. in Symposium Proceedings. Fourth Symposium of Turkish Society of Periodontology. October 21–22, 1994, Istanbul. ed. Özen Tuncer, Serdar Mutlu, Irfan Cebeci, Alpdogan Kantarci, ErOfset, Istanbul, Turkey, 1996, p. 87 - 102.
  2. Van Dyke TE, Kantarci, A., Pouliot, M., Clish, C.B., Oyaizu, K., Serhan, C.N. Novel Signals and Mechanisms in Localized Aggressive (Juvenile) Periodontitis: Defects and Implications for Treatments. In Periodontal Tissue Destruction and Remodeling ed. Ozen Tuncer, Serdar Mutlu, and Crispian Scully. Quintessence Ltd. Istanbul, 2003. pp. 53-66.
  3. Hasturk, H, Kantarci, A., Van Dyke, T.E. Control of Inflammation in Periodontal Disease. In Periodontal Medicine and Systems Biology. Ed. Brian Henderson, Michael A. Curtis, Robert M. Seymour, and Nikos Donos. Wiley-Blackwell, Oxford, United Kingdom, 2009. pp. 299 – 316.
  4. Kantarci, A., Hasturk, H., Van Dyke, T.E. Oral Inflammation and Periodontitis. In Fundamentals of Inflammation. Ed. Charles N. Serhan, Peter A. Ward, and Derek W. Gilroy, Cambridge University Press, New York, New York, 2010. pp. 433 – 447.
  5. Hasturk, H, Kantarci, A., Van Dyke, T.E. Immediate Implant Stability and Function: Biomechanics and Electron Microscopy. Ed. Sasaki K, Suzuki O, Takahashi N, Stashenko P, Van Dyke TE, Kawai T, Hasturk H, Kantarci A. Interface Oral Health Science 2011, Springer, 2012. pp. 376 – 382.
  6. Hasturk, H, Kantarci, A., Van Dyke, T.E. Immediate Implant Stability and Function: A Minipig Model and Surgical Technique. Ed. Sasaki K, Suzuki O, Takahashi N, Stashenko P, Van Dyke TE, Kawai T, Hasturk H, Kantarci A. Interface Oral Health Science 2011, Springer, 2012. pp. 376 – 382.
  7. Almpani K, Kantarci A. Front Oral Biol. 2015; 18: 80-91.
  8. Almpani K, Kantarci A. Front Oral Biol. 2015; 18: 92-101.
  9. Kantarci A, Yen S, Will LA. Front Oral Biol. 2015; 18: 130.
  10. Kantarci A. Gingival Overgrowth. Carranza’s Textbook of Clinical Periodontology. 13th Edition. 2018
  11. Kantarci A, Hasturk H. Periodontitis and Systemic Diseases (cardiovascular disease and diabetes): Biological perspectives for oral/periodontal implications. Lindhe’s Textbook of Clinical Periodontology. 7th Edition. 2020
  12. Kantarci A, Marchesan J, Divaris K. Gingival Enlargement and Management. Carranza’s Textbook of Clinical Periodontology. 14th Edition. 2022

 

Book Editor

  1. Symposium Proceedings. Fourth Symposium of Turkish Society of Periodontology. October 21–22, 1994, Istanbul. ed. Özen Tuncer, Serdar Mutlu, Irfan Cebeci, Alpdogan Kantarci, ErOfset, Istanbul, Turkey, 1996.
  2. Interface Oral Health Science 2011 ed Sasaki K, Suzuki O, Takahashi N, Stashenko P, Van Dyke TE, Kawai T, Hasturk H, Kantarci A. Springer, 2012
  3. Tooth Movement ed Kantarci A, Will LA, Yen S. Karger 2015
  4. Kantarci A. Biological Basis of Periodontal Regeneration. Dent Clin North Am. 2022 Jan 

 

Invited Conference Lectures

  1. Kantarci A. Role of Lipid Mediators in Pathogenesis and Treatment of Periodontal Diseases. Turkish Society of Periodontology 36th Scientific Congress September 21-23, 2006, Izmir, Turkey.
  2. Kantarci A. Endogenous Anti-Inflammatory Lipid Mediators in Prevention and Treatment of Periodontal Disease. Pathology Seminar Series. Boston University School of Medicine Department of Pathology. October 20, 2006, Boston MA.
  3. Kantarci A. Periodontal and Biological Response to Alveolar Decortication in the Rat Model. Symposium on Rapid Orthodontics Following Selective Alveolar Decortication Sponsored by Craniofacial Biology, Periodontal Research International Association for Dental Research General Session. March 21-24, 2007 New Orleans.
  4. Kantarci, A. New Ways for Resolution of Inflammation in Periodontitis, Lunch & Learn Table Clinic Presentation. International Association for Dental Research General Session. July 2-5, 2008 Toronto, Canada.
  5. Kantarci, A. Anti-inflammatory Periodontal Drug Therapy. Annual Meeting of German Society of Periodontology, September 26-27, 2008, Nurnberg, Germany.
  6. Kantarci, A. Neutrophil Function in Localized Aggressive Periodontitis. Justus Liebig University of Giessen, Graduate School for the Life Sciences, September 30, 2008, Giessen, Germany.
  7. Kantarci, A. Lipid Mediators in Activation and Resolution of PMN-mediated Inflammatory Responses. The Forsyth Institute, October 16, 2008 Boston, USA.
  8. Kantarci, A. Epithelial and Connective Tissue Cell CTGF/CCN2 Expression in Gingival Fibrosis: Role of Epithelial-Mesenchymal Transition. 5th CCN Workshop. October 20, 2008, Toronto, Canada.
  9. Kantarci, A. Subgingival Irrigation System: Myth or Reality. 33rd National Annual Conference of Indian Society of Periodontology, November 17-18, 2008 Chandigarh, India.
  10. Kantarci, A. Biological response to corticotomy-facilitated tooth movement. 33rd National Annual Conference of Indian Society of Periodontology, November 17-18, 2008 Chandigarh, India.
  11. Kantarci, A. Resolution of periodontal inflammation. February 25, 2009, University of Bern, Switzerland.
  12. Kantarci, A. Lipid Mediators in Activation and Resolution of Neutrophil Function and Periodontal Inflammation. The Forsyth Institute, July 21, 2009 Boston, USA.
  13. Kantarci, A. Lipid Mediators in Activation and Resolution of Neutrophil Function and Periodontal Inflammation. Boston University, September 22, 2009 Boston, USA
  14. Kantarci, A. Lipid Mediators and Neutrophil Function. Columbia University, June 18, 2010, New York, USA.
  15. Kantarci, A. Animal Models for Periodontal Disease and Inflammation, July 17, 2010. International Association for Dental Research General Session. Barcelona, Spain.
  16. Kantarci, A. Lipid Mediators in Activation and Resolution of Neutrophil Function and Periodontal Inflammation. Harvard University, September 21, 2010 Boston, USA
  17. Kantarci, A. Inflammation and Hypoxia: How does it relate to Oral Diseases? Boston University, October 19, 2010 Boston, USA
  18. Kantarci A. Histopathological Evaluation of Newly-Formulated Synthetic Graft Material around Immediate Implants: Tissue Response to Immediate Function. Harvard University, January 6, 2011.
  19. Kantarci A. Collaborative Prevention and Management of Inflammatory Diseases:
    Periodontitis and Diabetes. Forsyth Prevention Symposium, Boston, May 6, 2011
  20. Kantarci A. Animals Models in Periodontology and Implantology Research. Turkish Society of Periodontology Meeting, Istanbul, Turkey, May 21, 2011.
  21. Kantarci A. Periodontal Inflammation: Hypoxia-mediated Tissue Destruction and Resolution. International Academy of Periodontology Meeting, Lviv, Ukraine, June 17, 2011.
  22. Kantarci A. Biological Basis of Photobiomodulation-Induced Orthodontic Tooth Movement. Biolux Research Symposium, Las Vegas, USA June 25, 2011.
  23. Kantarci A. Localized Aggressive Periodontitis: What do we know? University of Bonn, Bonn, Germany, July 5, 2011.
  24. Kantarci A. Biological Basis of Orthodontic Tooth Movement: Clinical Implications. Boston University Department of Orthodontics, Boston USA August 2, 2011
  25. Kantarci A. Inflammation and Biological Mechanisms Underlying Alveolar Bone Response to Orthodontic Tooth Movement. Stony Brook University, Stony Brook, NY, USA February 27, 2012
  26. Kantarci A. Photobiomodulation‐Induced Orthodontic Tooth Movement: Where are we in understanding the Biological Mechanism? Biolux Light Accelerated Orthodontics and Bone Regeneration Clinical and Scientific Conference. Honolulu, Hawaii, USA May 3-4, 2012
  27. Kantarci A. Biological Mechanisms Underlying Alveolar Bone Response to Orthodontic Tooth Movement. American Association of Orthodontists (AAO) Annual Meeting. Honolulu, Hawaii, USA, May 5, 2012.
  28. Kantarci A. Pathogenesis of Periodontitis: What do we know? Hungarian Society of Periodontology and Implantology. Szeged, Hungary, May 18, 2012.
  29. Kantarci A. High-throughput Methods: Inflammatory Basis of Disease. Procter and Gamble, Cincinnati, Ohio, USA, June 1, 2012.
  30. Kantarci A. Aetiology and pathogenesis of periodontal diseases: challenging the paradigm. EuroPerio 7 Meeting, Vienna, Austria, June 8, 2012.
  31. Kantarci A. Mechanism of Orthodontic Tooth Movement, University of Kentucky, Lexington, Kentucky, USA, September 12, 2012.
  32. Kantarci A. Biological Mechanism to Corticotomy-Assisted Tooth Movement and Impact of Photobiomodulation. AEEDC 2013, Dubai, UAE, February 5, 2013.
  33. Kantarci A. Involvement of Vitamin D During Photobiomodulation-Induced Orthodontic Movement. Biolux Light Accelerated Orthodontics and Bone Regeneration Clinical and Scientific Conference 2013, Dubai, UAE, February 6, 2013.
  34. Kantarci A. Inflammation and hypoxia: How does it relate to periodontal diseases? University of Florida, Gainesville, Florida, USA, March 7, 2013.
  35. Kantarci A. Hypoxia and Periodontal Inflammation, Harvard University, Boston, MA, USA, April 4, 2013.
  36. Kantarci A. Hypoxia and Periodontal Inflammation:  Life in the Pocket, University of Kentucky, Lexington, Kentucky, USA, April 5, 2013
  37. Kantarci A. Periodontal Disease. International Academy of Periodontology Meeting, Shenzen, China, May 31, 2013
  38. Kantarci A. Biological Response to Orthodontic Tooth Movement: Impact of Photobiomodulation. Boston University, Boston, USA, July 25, 2013
  39. Kantarci A. Host Modulation Therapy in Periodontology. FDI General Assembly Meeting, Istanbul, Turkey, August 31, 2013
  40. Kantarci A. Role of Epithelial Mesenchymal Transition in Pathogenesis of Gingival Fibrosis. University of Zurich. Zurich, Switzerland, September 2, 2013
  41. Kantarci A. Novel Therapeutic Strategies to Restore the Homeostasis of the Periodontium. Swiss Society of Periodontology, Annual Meeting, Fribourg, Switzerland, September 5, 2013
  42. Kantarci A. Biological Response to Orthodontic Tooth Movement. Boston University, Boston, USA, September 23, 2013
  43. Kantarci A. Pathogenesis of Periodontitis. First International Perio-Transylvania Symposium, Sibiu, Romania, April 10-12, 2014
  44. Kantarci A. High-Throughput Analyses of Salivary Biomarkers of Inflammation. University of Florida, Gainesville, USA, April 18, 2014
  45. Kantarci A. Mechanism of Light Accelerated Orthodontic Tooth Movement: Potential Factors Involved in Regulation of Bone Response, New Orleans, LA, USA, April 26, 2014
  46. Kantarci A. Resolvins for Prevention and Treatment of Periodontitis, Forsyth Institute, Cambridge, MA, May 2014
  47. Kantarci A. Life of a Dentist, Harvard School of Dental Medicine, Boston, MA, USA, May 2014
  48. Kantarci A. Resolution of Inflammation: Novel Therapeutic Strategies to Restore the Homeostasis. Procter & Gamble, Cincinnati, OH, USA, May 2014
  49. Kantarci A. High-Throughput Analyses of Salivary Biomarkers of Inflammation, University of Sao Paulo, Brazil, June 2014
  50. Kantarci A. Biological Response to Orthodontic Tooth Movement, University of Sao Paulo, Brazil, June 2014
  51. Kantarci A. Infecto-Inflammatory Pathogenesis of Periodontitis: Role of Host or Life in the Pocket, University of Sao Paulo, Brazil, June 2014
  52. Kantarci A. Role of Epithelial Mesenchymal Transition in Pathogenesis of Gingival Fibrosis, University of Sao Paulo, Brazil, June 2014
  53. Kantarci A. Dental Cardiovascular Risk. Joslin Diabetes Center Mini-Symposium: “It’s related to Cardiometabolic Risk? I didn’t know that!”. Boston, MA, USA, June 2014
  54. Kantarci A. Link Between Periodontal Diseases and Cardiovascular Diseases, Indian Society of Periodontology Colloquium Series, Delhi, India, September 2014.
  55. Kantarci A. Link Between Periodontal Diseases and Cardiovascular Diseases, Indian Society of Periodontology Colloquium Series, Kolkata, India, September 2014.
  56. Kantarci A. Link Between Periodontal Diseases and Cardiovascular Diseases, Indian Society of Periodontology Colloquium Series, Bangalore, India, September 2014.
  57. Kantarci A. Mechanism of Light-Accelerated Orthodontic Tooth Movement: Potential Factors Involved in Regulation of Bone Response. Schulman Study Group, Austin, TX, USA, September 19, 2014
  58. Kantarci A. Biological Basis of Accelerated Orthodontic Treatment, Turkish Society of Orthodontists Annual Meeting, Ankara, Turkey, October 2014
  59. Kantarci A. Inflammation as a Mechanism and Therapeutic Concept in Periodontal Diseases, Istanbul University, Istanbul, Turkey, November 2014
  60. Kantarci A. Aging and Periodontal Tissues. IADR, Boston, March 2015
  61. Kantarci A. Hypoxia and Periodontal Inflammation. Lion-Forsyth Symposium, Cambridge, March 2015
  62. Kantarci A. Saliva Diagnostics as a Tool for Biomarker Analyses for Inflammatory Diseases, Massachusetts Institute of Technology, Cambridge, May 2015
  63. Kantarci A. Inflammatory Basis of Diabetes and Periodontal Disease Link. Turkish Dental Association Annual Meeting, Istanbul, May 2015
  64. Hasturk H, Kantarci A. Clinical Research in Dentistry and the Role of Laboratory Analyses. Barts and the London School of Medicine and Dentistry, London, June 2015.
  65. Kantarci A. Prospects for Use of Pro-resolution Biologicals. EuroPerio 8, London, June 2015
  66. Kantarci A. Salivary Biomarkers and new High Throughput Technologies, Cologne, September 2015.
  67. Kantarci A. New Platform Designs for Biomarker Detection, Massachusetts Institute of Technology (MIT) Media Lab, September 2015
  68. Kantarci A. Biological Basis, Techniques, and Innovations in Accelerated Orthodontics. Istanbul, November 2015
  69. Kantarci A. Role of vascularization and hypoxia in periodontal disease. Turkish Society of Periodontology Annual Meeting, Ankara, November 2015
  70. Kantarci A. Hypoxia and Periodontal Inflammation: Life in the Pocket. University of Pennsylvania, November 2015
  71. Kantarci A. Photobiomodulation and Biology: What have we learned? Biolux Advisory Board Meeting. Key Note Lecture. Las Vegas, November 2015
  72. Kantarci A. Periodontal Disease and Pathogenesis. Colombian Society of Periodontology Meeting, Bogota, March 2016
  73. Kantarci A. Role of the Host in Periodontal Disease Pathogenesis, Unersity at Buffalo, Buffalo, May 2016.
  74. Kantarci A. Current Concepts for Accelerated Tooth Movement. IADR, Seoul, Korea, June 2016.
  75. Kantarci A. Role of the Host in Periodontal Disease Pathogenesis. Medical University of Warsaw, September 2016
  76. Kantarci A. Activation and Resolution of Periodontal Inflammation, FDI Annual Meeting, Poznan, Poland, September 2016
  77. Kantarci A. Mechanism of Accelerated Orthodontic Tooth Movement, FDI Annual Meeting, Poznan, Poland, September 2016
  78. Kantarci A. Photodynamic Therapy in the Treatment of Periodontitis and Peri- implantitis and Innovations in Implantology, Theoretical Workshop, 16th International Biennial Congress of the International Academy of Periodontology, Brasov, Romania, April 2017
  79. Kantarci A. Mechanism of Accelerated Orthodontic Tooth Movement. Perio-Ortho Connection Symposium, 16th International Biennial Congress of the International Academy of Periodontology, Brasov, Romania, April 2017
  80. Kantarci A. Host-Associated Factors in Periodontal Disease Pathogenesis, 16th International Biennial Congress of the International Academy of Periodontology, Brasov, Romania, April 2017
  81. Kantarci A. Inflammation and Periodontal Disease: New Opportunities in Therapy and Impact on Systemic Health. University of Bergen, Bergen, Norway, May 2017
  82. Kantarci A. Hypoxia and its Impact on Periodontal Tissues as a Modification of the Infecto-Inflammatory Pathogenesis. University of Birmingham, United Kingdom, May 2017
  83. Kantarci A. Light-Accelerated Orthodontics: Beyond Acceleration? Biolux Symposium. European Orthodontic Society Annual Meeting, Montreux, Switzerland, June 2017
  84. Kantarci A. Mechanism of Photobiomodulation-Accelerated Orthodontic Tooth Movement. European Orthodontic Society Annual Meeting, Montreux, Switzerland, June 2017
  85. Kantarci A. Hypoxia and Host Response. Penn Periodontal Conference, University of Pennsylvania, Philadelphia, June 2017
  86. Kantarci A. Modulation of Inflammation as a Treatment of Periodontal Disease and a Regenerative Approach. Scandinavian Society of Periodontology Meeting, Mariehamn, Aaland Islands, Finland, August 2017
  87. Kantarci A. What Science is Behind Accelerated Tooth Movement (and Does it Exist?). Anthony Gianelly Symposium. Boston, October 2017
  88. Kantarci A. Biological basis of periodontal and systemic disease link at the cellular and molecular level with potential mechanisms of treatment. Federation of IberoAmerican Periodontology (FIPP) Meeting, Santiago, Chile, November 2017
  89. Kantarci A. Treatment of periodontal disease: A regenerative approach. University of Chile, Santiago, Chile, November 2017
  90. Kantarci A. Reducing Plaque Virulence Factors New Angle to Promote Periodontal Health, Procter and Gamble US-China Experts Meeting, Beijing, China, December 2017
  91. Kantarci A. Multi-Decade Assessment of Histomorphology and Gene Expression in Gingival Tissues in Healthy Adults, Procter and Gamble Innovation Center, Beijing, China, December 2017.
  92. Kantarci A. Host-Microbiome Interactions in a Complex Microenvironment as a Mechanism of Periodontitis and Potential Targets for Novel Therapeutics, Capital Medical University of Beijing, China, December 2017
  93. Kantarci A. Host-Microbiome Interactions in a Complex Microenvironment as a Mechanism of Periodontitis and Potential Targets for Novel Therapeutics. University of Alabama, Birmingham, Alabama, December 2017.
  94. Kantarci A. Host-Microbiome Interactions in a Complex Microenvironment as a Mechanism of Periodontitis and Potential Targets for Novel Therapeutics. Polish Society of Periodontology Meeting. Warsaw, Poland, February 2018.
  95. Kantarci A. Host-Microbiome Interactions and the Impact of Environment on Periodontal Disease. University of Florida, Gainesville, Florida, March 2018.
  96. Kantarci A. What Science is Behind Accelerated Tooth Movement (and Does it Exist?). University of Nova, Ft. Lauderdale, Florida, March 2018.
  97. Kantarci A. Initiation of Inflammation – Role of Phagocytes. AADR Annual Meeting, Ft. Lauderdale, Florida, March 2018.
  98. Kantarci A. Science Behind Accelerated Tooth Movement. CTOR Meeting, Hoboken, New Jersey, March 2018.
  99. Kantarci A. Host-Microbiome Interactions in a Complex Microenvironment as a Mechanism of Periodontitis and Potential Targets for Novel Therapeutics. University of Western Ontario, London, Ontario, Canada, May 2018.
  100. Kantarci A. Role of macrophages and signaling in periodontal disease-systemic disease connection. Griffith University, Brisbane, Australia, May 2018.
  101. Kantarci A. Periodontal Approaches to Accelerated Orthodontics and Biological Mechanism. ANZAP Meeting, Brisbane, Australia, May-June 2018.
  102. Kantarci A. Is inflammation the link between periodontal and systemic diseases? ANZAP Meeting, Brisbane, Australia, May-June 2018.
  103. Kantarci A. Host response as a modulating factor for periodontal bacteria: Implications for therapy. ANZAP Meeting, Brisbane, Australia, May-June 2018.
  104. Kantarci A. Physical activity modulates inflammation. EuroPerio9, Amsterdam, June 2018.
  105. Kantarci A. Bone Response to Conventional and Accelerated Orthodontic Tooth Movement, IADR Symposium, London-England, July 2018.
  106. Kantarci A. Oral to systemic disease-The mouth/body connection. P&G Summit on Aging and Oral Diseases. Cincinnati, August, 2018.
  107. Kantarci A. Impact of Aging on Periodontal Tissues. Turkish Dental Association Meeting, Ankara-Turkey, September, 2018.
  108. Kantarci A. Mechanisms linking periodontitis and systemic diseases. International Academy of Periodontology Research Conference. Giessen-Germany, October, 2018.
  109. Kantarci A. Periodontal Disease and Systemic Health: A two-way link? FINDOS Seminar, Helsinki-Finland, December, 2018
  110. Kantarci A. Oral Systemic Wellness in Practice: Putting Knowledge into Action. Yankee Dental Congress, Boston, January, 2019
  111. Kantarci A. Molecular mechanism of the inflammatory link between periodontal diseases and diseases in distant organs. Rutgers University, Newark, March, 2019
  112. Kantarci A. Impact of activation and resolution of inflammation on periodontal disease and therapy. Suleyman Demirel University, Isparta, Turkey, April 2019
  113. Kantarci A. Etiology and pathogenesis of periodontitis and periimplantitis. Eastern European Implant Congress, Lviv, Ukraine, April 2019
  114. Kantarci A. Impact of Aging on Periodontal and Periimplant Tissues. Eastern European Implant Congress, Lviv, Ukraine, April 2019
  115. Kantarci A. Periodontics in the 21st Century. A&H Lecture Series, Tokyo, Japan, May 2019
  116. Kantarci A. Accelerated Orthodontics in the 21st Century. A&H Lecture Series, Tokyo, Japan, May 2019
  117. Kantarci A. Oral and Systemic Disease Connection. IAP Meeting-Joint Symposium of IAP and JSP, Bangkok, Thailand, June 2019
  118. Kantarci A. Host Response, Biomarkers and Periodontitis Diagnosis. IADR-Symposium, Vancouver, Canada, June 2019
  119. Kantarci A. Molecular Changes Involved in the Progression of Gingivitis to Periodontitis. IADR-Chilean Division Meeting, Santiago, Chile, August 2019
  120. Kantarci A. How can Oral Diseases Impact the Pathologies of Distant Organs? IADR-Chilean Division Meeting, Santiago, Chile, August 2019
  121. Kantarci A. Acceleration of Orthodontic Tooth Movement: Biological Mechanisms and Clinical Implications. IADR-Chilean Division Meeting, Santiago, Chile, August 2019
  122. Kantarci A. Invasive and Non-invasive Methods in Accelerated Orthodontics. First International Conference of Dentistry, Kayseri, Turkey, February 2020.
  123. Kantarci A. Role of Inflammation as Link between Systemic Diseases, Periodontitis and Periimplantitis. First International Conference of Dentistry, Kayseri, Turkey, February 2020.
  124. Kantarci A. Novel Concepts in Regenerative Periodontal Medicine: Outlook for the Future. EuroPerio Master Clinic. Dublin, Ireland, March 2020.
  125. Kantarci A. Bone Response to Orthodontic Treatment. Turkish Society of Orthodontics. May 2020 (Webinar)
  126. Kantarci A. Saliva and COVID-19 Testing in Clinical Dental Practice. Forsyth Institute. May 2020 (Webinar)
  127. Kantarci A. Bone biology and orthodontic treatment: Case study for designing and publishing
    dental research. IADR Saudi Division. June 2020 (Webinar)
  128. Kantarci A. Implant Strategies in Patients with History of Periodontitis and the Impact of Aging. Turkish Association of Osseointegration (Osseder). July 2020 (Webinar)
  129. Kantarci A. Resolution of Inflammation in Complex Systemic Diseases Linked to Periodontal Diseases. German Society of Periodontology (DG-PARO) Annual Meeting, Stuttgart, Germany. September 2020 (Webinar)
  130. Kantarci A. Scientific Research Methodology: From Planning to Publication. Turkish Association of Osseointegration (Osseder). October 2020 (Webinar)
  131. Kantarci A. Alzheimer’s disease, periodontitis, and systemic inflammation. DentaQuest-Forsyth Institute Joint Partnership Seminar. October 2020 (Webinar)
  132. Kantarci A. Periodontal Ligament Stem Cells and Inflammation. AADR Boston Section 2020 Fall Meeting. November 2020 (Webinar)
  133. Kantarci A. Periodontal Immunology and Inflammation. University of Geneva. Department of Periodontology. November 2020 (Webinar)
  134. Kantarci A. Research and Dentistry Education: Implications for Today and Future. JISP and JIAP Joint Symposium. March 2021 (Webinar)
  135. Kantarci A. Inflammation as a Link between Periodontal and Systemic Diseases. Oral Microbiology and Immunology Group of United Kingdom. March 2021 (Webinar)
  136. Kantarci A. Inflammation and Periodontal Ligament Cell Function. Gazi University Symposium. March 2021 (Webinar)
  137. Kantarci A. Forsyth’s Contribution to Craniofacial Growth, Development, and Oral Health in Children: Historical Milestones and Future Perspectives: Forsyth Twin Study. Shanghai-Forsyth Joint Symposium. April 2021 (Webinar)
  138. Kantarci A. Peri-implant Diseases and Treatment Options. Academy of Osseointegration Seminar Series. April 2021 (Webinar)
  139. Kantarci A. Treating the Aging Population. Massachusetts Dental Society Southeastern District Meeting. May 2021 (Webinar)
  140. Kantarci A. Science behind Photobiomodulation: understanding how it works. PBM Healing Ortho Webinar Series. May 2021 (Webinar)
  141. Kantarci A. Association Between Periodontitis and Alzheimer`s Disease: From Preclinical Models to Clinical Studies. IADR Symposium, July 2021 (Webinar)
  142. Kantarci A. Geriatric periodontology: Impact of inflammation, prediction of treatment outcomes and maintenance. IAP and ACPO Meeting, Cartagena, Colombia, September 2021.
  143. Kantarci A. Mechanistic Link between Alzheimer’s Disease and Periodontal Disease. University at Buffalo, September 2021.
  144. Kantarci A. Photobiomodulation in Dentistry. PBM Healing Ortho Webinar Series. September 2021 (Webinar)
  145. Kantarci A. Inflammatory Link between Periodontal and Systemic Diseases. Sivas Cumhuriyet University Scientific Meeting. November 2021 (Webinar)
  146. Kantarci A. Adjunctive Host-modulating Agents in Periodontal Therapy. EFP Virtual EuroPerio Series. December 2021 (Webinar)
  147. Kantarci A. Biological Basis of Periodontal Regeneration Part I. Hacettepe University Lecture Series. January 2022. (Webinar)
  148. Kantarci A. Inflammation as a Mechanistic Link Between Periodontal Diseases and Systemic Diseases. Forsyth-Kuwait School Oral Health Program (SOHP) Seminar Series. January 2022. (Webinar)
  149. Kantarci A. Inflammation as Link Between Periodontal Disease and Alzheimer`s Disease. Symposium at the AADOCR, Atlanta March 2022.
  150. Kantarci A. Resolution of Periodontal Inflammation. University of Sao Paolo, May 2022 (Webinar)
  151. Kantarci A. Biological Basis of Periodontal Regeneration Part II. Hacettepe University Lecture Series. May 2022. (Webinar)
  152. Kantarci A. Bases for anti-inflammatory and host-modulatory strategies in therapy. EuroPerio 10. Copenhagen, Denmark. June 2022
  153. Kantarci A. Periodontal Ligament Stem Cells in Translational Periodontal Regenerative Medicine. Workshop on Translational Oral Research (TOR). Bergen, Norway. June 2022
  154. Kantarci A. Inflammation as a Mechanistic Link Between Periodontal Diseases and Systemic Diseases. Roseman University Research Seminar Series, July 2022 (Webinar)
  155. Kantarci A. Inflammation as Link Between Periodontal Disease and Alzheimer`s Disease. Forsyth-UNG Symposium, Forsyth Institute, Cambridge, July 2022
  156. Kantarci A. Link between Alzheimer’s Disease, Aging, and Periodontal Disease. Turkish Dental Association Meeting, Istanbul, Turkey, September 2022
  157. Kantarci A. Dentist of the twenty-first century. Bursa Uludag University, Bursa, Turkey, September 2022.
  158. Kantarci A. Science behind Photobiomodulation: understanding how it works. A&H Series, Tokyo, Japan, November 2022.
  159. Kantarci A. Biological basis of periodontal regeneration. Ege University, Izmir, Turkey, January 2023.
  160. Kantarci A. Dentist of the twenty-first century. Ege University, Izmir, Turkey, January 2023.
  161. Kantarci A. Resolution of inflammation. Ege University, Izmir, Turkey, January 2023.
  162. Kantarci A. Postgraduate education in dentistry. Ege University, Izmir, Turkey, January 2023.
  163. Kantarci A. Biological basis of accelerated tooth movement. Ege University, Izmir, Turkey, January 2023.
  164. Kantarci A. Aging in periodontal tissues and systemic diseases. Symposium on Aging and Periodontal Diseases. Ege University, Izmir, Turkey, January 2023.
  165. Hasturk H, Kantarci. Research Design and Methodology for Clinical and Translational Research Workshop. Nova Southeastern University, Fort Lauderdale, FL, April 2023
  166. Kantarci A. Novel Concepts: Outlook for the Future. EuroPerio Master Clinic. Leon, Mexico, May 2023
  167. Kantarci A. Biological Basis of Periodontal Regeneration. Istanbul Kent University, Istanbul, Turkey, May 2023 (online)
  168. Kantarci A. Integrating and Clinical Translation of Research in Dentistry: 
    A Multi-disciplinary Approach, Challenges and Opportunities, University of Minnesota, June 2023
  169. Kantarci A. Infectious and Immunological Basis of Periodontal Disease Pathogenesis. International Academy of Periodontology Meeting, Dubrovnik, Croatia, September 2023
  170. Kantarci A. Accelerated Orthodontics. Gianelly Symposium. Boston University, Boston, MA, October 2023
  171. Kantarci A. Inflammation and Wound Healing. Ankara University, Ankara, Turkey, October 2023
  172. Kantarci A. The Link between Neurodegenerative Diseases and Periodontal Disease, Annual Meeting of Turkish Dental Association, Ankara, Turkey, October 2023
  173. Kantarci A. Periodontal Disease and Alzheimer’s Disease: Mechanisms of Association and Therapeutic Strategies. Genco Symposium, Annual Meeting of American Academy of Periodontology, Austin, Texas, November 2023.
  174. Kantarci A. Periodontal Immunology and Inflammation. University of Geneva, Invited Lecture Series, Geneva, Switzerland, November 2023 (webinar)
  175. Kantarci A. Science behind photobiomodulation: understanding how it works. Swedish-Japanese Dental Academy Conference, Tokyo, Japan, December 2023
  176. Kantarci A. Systemic Diseases and Oral Diseases: Treating the Aging Population. Boston University, Boston, December 2023.
  177. Kantarci A. Resolvins and Specialized Mediators of Inflammation in Alzheimer’s Disease and Oral Inflammation. Symposium on Resolution of Inflammation in Medicine and Surgery, Harvard Medical School, Boston, February 2024
  178. Kantarci A. Inflammatory and Microbial Link Between Periodontal and Neurodegenerative Diseases. Nova Southeastern University Dental Symposium 2024. AADOCR Florida-JSPS Joint Meeting. February 2024
  179. Kantarci A. Mechanism of the Inflammatory and Microbial Link Between Periodontal and Neurodegenerative Diseases. Istanbul Atlas University. Istanbul, Turkey, February 2024.
  180. Kantarci A. Mechanistic Understanding into the Link Between Periodontal and Neurodegenerative Diseases. IADR Symposium, New Orleans, March 2024.
  181. Kantarci A.  Systemic Diseases and Oral Diseases. CTOR Academy Lecture Series, April 2024 (webinar)
  182. Kantarci A. Systemic Diseases and Oral Diseases or Treating the Aging Population. MDS Cape Cod District Meeting, May 2024.
  183. Kantarci A. Systemic Diseases and Oral Diseases in the Aging Population. Dentistry Congress at Tecnológico de Monterrey: Odontalks, Monterrey, Mexico, May 2024
  184. Kantarci A. Inflammation and Periodontal Healing. Dentistry Congress at Tecnológico de Monterrey: Odontalks, Monterrey, Mexico, May 2024
  185. Kantarci A. Science behind Photobiomodulation: understanding how it works. A&H Academy June 2024 (Webinar)
  186. Kanarci A. Mechanistic Link Between Periodontal and Neurodegenerative Diseases. Colombian Society of Periodontology and Osseointegration (ACPO) Annual Meeting, August 2024, Cartagena, Colombia.
  187. Kantarci A. Oral-Systemic Link: Translational Implications in Dentistry 
    A Multi-disciplinary Approach, Challenges and Opportunities. August 2024, Harvard University, Boston
  188. Kantarci A. Periodontal Inflammation, Resolution and Periodontal Healing. University of Sao Paulo, September 2024, Sao Paulo, Brazil (webinar)
  189. Kantarci A. Alzheimer’s Disease and the Oral-Systemic Puzzle: Making Sense. Making Change. ADA Smilecon Annual Meeting, October 2024, New Orleans
  190. Kantarci A. Non-invasive Methods in Acceleration of Orthodontic Tooth Movement. Turkish Orthodontic Society Webinar Series, October 2024 (webinar)
  191. Kantarci A. Infection and Inflammatory Process as a Link between Periodontitis and 
    Systemic Diseases. Beth Israel Deaconess Medical Center, Department of Gastroentereology Grand Rounds Series, October 2024, Boston
  192. Kantarci A. From Health to Disease: Paradigm Change in Periodontology. Istanbul University, November 2024, Istanbul, Turkey
  193. Kantarci A. Inflammation and Periodontal Regeneration. Turkish Society of Periodontology Annual Meeting, November 2024, Antalya, Turkey
  194. Kantarci A. Dentistry in 21st Century. 19 Mayis University Scientific Meeting, November 2024, Samsun, Turkey (webinar)
  195. Kantarci A. ADEA-CODA, Accreditation Process in the US Schools. UDEG Meeting, February 2025, Bolu, Turkey
  196. Kantarci A. Neurodegenerative Diseases and Oral Health, University of Minnesota CE Lecture Series. March 2025, Minneapolis
  197. Kantarci A. Oral Microbiome Signatures in Saliva in Patients with Systemic Diseases: How the Neurodegenerative Diseases Present an Opportunity to Study Oral-Systemic Dissemination. AADOCR Annual Meeting, March 2025, New York City
  198. Kantarci A. Biological Basis of Periodontal Regeneration, Turkish Society of Periodontology Regional Meeting, April 2025, Malatya, Turkey
  199. Kantarci A. Mechanistic Link Between Oral and Systemic Diseases: Lessons Learned from 
    Neurodegenerative Diseases and Oral Health. University of North Carolina. May 2025, Chapel Hill, NC
  200. Kantarci A. Can we Personalize Anti-inflammatory Therapy? EuroPerio 11, May 2025, Vienna, Austria

 

Oral and Poster Presentations

More than 500 presentations between 1993 and 2025.